<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS199386</article-id><article-id pub-id-type="doi">10.1101/2024.10.08.617210</article-id><article-id pub-id-type="archive">PPR923578</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>WNT-mediating TCF/LEF transcription factor gene expression in early human pluripotency and cell lineages differs from the rodent paradigm</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ross</surname><given-names>Connor</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Azami</surname><given-names>Takuya</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Salonna</surname><given-names>Marika</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gyuris</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Nichols</surname><given-names>Jennifer</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hoppler</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><aff id="A1"><label>1</label>Institute of Medical Sciences, Foresterhill Health Campus, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/016476m91</institution-id><institution>University of Aberdeen</institution></institution-wrap>, <postal-code>AB25 2ZD</postal-code>, <city>Scotland</city>, <country>UK</country></aff><aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/011jsc803</institution-id><institution>MRC Human Genetics Unit</institution></institution-wrap>, Institute of Genetics and Cancer, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01nrxwf90</institution-id><institution>The University of Edinburgh</institution></institution-wrap>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/009kr6r15</institution-id><institution>Western General Hospital</institution></institution-wrap>, <addr-line>Crewe Road</addr-line>, <city>Edinburgh</city><postal-code>EH4 2XU</postal-code></aff></contrib-group><author-notes><corresp id="CR1"><label>*</label>Correspondence: Stefan Hoppler (<email>s.p.hoppler@abdn.ac.uk</email>)</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>14</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>12</day><month>10</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Embryonic stem cell research has uncovered different requirements for WNT/β-catenin signalling in human naïve pluripotent cells compared to the mouse paradigm. It is therefore important to study WNT/β-catenin signalling directly in models of early human development. Since TCF/LEF factors mediate the regulation of target genes downstream of WNT/β-catenin signalling, we studied the expression and protein localisation of the four TCF/LEF genes by analysing <italic>in vitro</italic> “snapshots” of human development, leveraging naïve and primed pluripotent cells as well as extraembryonic and early embryonic cell lineages. Strikingly, we comprehensively confirm clear differences between mouse and human pluripotent stem cells, suggesting species-specific requirements for WNT signalling that may reflect differences in states of pluripotency. Human naïve ES cells express very low TCF7L1, unlike their mouse counterparts. TCF7L2 is robustly expressed in human naïve ES-derived trophectoderm cells. In human primed pluripotent stem cells, activation of WNT/β-Catenin signalling is required to induce expression of both <italic>TCF7</italic> and <italic>LEF1</italic>, concomitant with hallmark gastrulation markers. This expression of human TCF/LEF genes benchmarks differential requirements for WNT/β-catenin signalling throughout early human embryo development that requires further investigation.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Stem cells isolated from the early embryo provide accessible experimental models for studying early embryonic development in cell culture, especially in the context of early human development. The stable stem cell cultures originally isolated from mouse embryos (<xref ref-type="bibr" rid="R19">Evans and Kaufman, 1981</xref>; <xref ref-type="bibr" rid="R63">Martin, 1981</xref>) differ from the first human embryonic stem cells (<xref ref-type="bibr" rid="R97">Thomson et al., 1998</xref>) in several respects, subsequently recognised to represent different states of pluripotency; naïve and primed, respectively (<xref ref-type="bibr" rid="R72">Nichols and Smith, 2009</xref>). Human embryonic stem cells can be cultured in conditions supportive of naïve pluripotency (<xref ref-type="bibr" rid="R6">Bayerl et al., 2021</xref>; <xref ref-type="bibr" rid="R12">Bredenkamp et al., 2019</xref>; <xref ref-type="bibr" rid="R26">Guo et al., 2017</xref>; <xref ref-type="bibr" rid="R27">Guo et al., 2016</xref>; <xref ref-type="bibr" rid="R42">Khan et al., 2021</xref>; <xref ref-type="bibr" rid="R93">Takashima et al., 2014</xref>) but they differ from mouse naïve embryonic stem cells in their less restricted potential to differentiate into extraembryonic lineages (<xref ref-type="bibr" rid="R25">Guo et al., 2021</xref>; <xref ref-type="bibr" rid="R52">Linneberg-Agerholm et al., 2019</xref>). Some of these differences in the naïve state between human and mouse models involves WNT/β-catenin signalling. For instance, WNT activation (as part of 2i+LIF) is required in culture conditions to sustain mouse naïve embryonic stem cells (<xref ref-type="bibr" rid="R106">Wray et al., 2011</xref>; <xref ref-type="bibr" rid="R113">Ying et al., 2008</xref>). Additionally, there are differences in expression of a downstream component of the Wnt/β-catenin pathway (i.e., TCF7L1 expression, <xref ref-type="bibr" rid="R85">Rostovskaya et al., 2019</xref>, and see below); and, probably related to that, of Wnt/β-catenin target genes such as <italic>Esrrb</italic> (<xref ref-type="bibr" rid="R62">Martello et al., 2012</xref>).</p><p id="P3">WNT signalling is a widely conserved biochemical cell-to-cell signalling network, which mediates diverse biological functions, including during early embryonic development and later tissue stem cell-mediated regeneration and disease (reviewed by <xref ref-type="bibr" rid="R30">Hoppler and Moon, 2014</xref>; <xref ref-type="bibr" rid="R73">Nusse and Clevers, 2017</xref>). The so-called canonical or WNT/β-catenin-dependent pathway is the best understood signal transduction pathway (reviewed by <xref ref-type="bibr" rid="R31">Hoppler and Nakamura, 2014</xref>). WNT signal transduction in WNT receiving cells consequently drives β-Catenin protein into the nucleus to regulate the transcription of context-specific WNT target genes in association with sequence-specific DNA-binding factors, primarily of the T Cell Factor (TCF) and Lymphoid Enhancer Factor (LEF) family (reviewed by <xref ref-type="bibr" rid="R13">Cadigan and Waterman, 2012</xref>; <xref ref-type="bibr" rid="R32">Hoppler and Waterman, 2014</xref>). These transcription factors function in a bimodal fashion to either repress target gene expression without and activate them with nuclear β-Catenin (reviewed by <xref ref-type="bibr" rid="R79">Ramakrishnan and Cadigan, 2017</xref>). Differences between human and mouse naïve embryonic stem cells may be attributable to divergent nuclear WNT/β-catenin pathway mechanisms and particularly to differences in TCF/LEF expression and function during early embryonic development. In vertebrates, there are four TCF/LEF genes; TCF7, TCF7L1 (formerly TCF3), TCF7L2 (formerly TCF4) and LEF1 (<xref ref-type="bibr" rid="R98">Torres-Aguila et al., 2022</xref>), which mediate different biological functions in a cell- and context-dependent manner that are not yet understood (reviewed by <xref ref-type="bibr" rid="R32">Hoppler and Waterman, 2014</xref>).</p><p id="P4">To advance our understanding of the WNT signalling in early human development and how it might deviate from the mouse model-derived paradigm, we studied the expression and localisation of all four TCF/LEF transcription factors during directed differentiation from naïve and primed state pluripotent stem cells into extra-embryonic and early embryonic cell lineages, respectively. These findings confirm clear differences with mouse and provide a solid conceptional platform for future investigation into the role of WNT signalling in early human embryogenesis.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Comparison of TCF/LEF expression between mouse and human in naïve and primed pluripotency</title><p id="P5">The mutually exclusive expression of naïve and primed markers can be used to characterise different pluripotent states. Mouse naïve embryonic stem cells robustly express Klf4 and Tcfp2l1, which is lost when cultured in primed conditions (AFX: <bold><underline>A</underline></bold>CTIVIN A, <bold><underline>F</underline></bold>GF2 and <bold><underline>X</underline></bold>AV9393), but both populations maintain homogeneous Oct4 expression (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). Human pluripotent cells in both naïve and primed states express NANOG and OCT4, whereas KLF17 is restricted to the naïve state (<xref ref-type="fig" rid="F1">Fig.1B</xref>)(<xref ref-type="bibr" rid="R9">Blakeley et al., 2015</xref>; <xref ref-type="bibr" rid="R88">Stirparo et al., 2018</xref>).</p><p id="P6">First, we studied TCF/LEF expression in mouse naïve (i.e., ESC) and primed (i.e., EpiSCs) pluripotent stem cells. Immunostaining revealed homogeneous expression of Tcf7 and Tcf7l1 in both naïve and primed states (<xref ref-type="fig" rid="F1">Fig. 1C</xref>), supported by flow cytometry (<xref ref-type="fig" rid="F1">Fig. 1D</xref>). We observed a small albeit significant increase in the number of Tcf7-expressing cells between naïve and primed cells (<xref ref-type="fig" rid="F1">Fig. 1D</xref>), whilst Tcf7l1 remained unchanged (<xref ref-type="fig" rid="F1">Fig. 1E</xref>). Tcf7l2 in naïve ES cells was homogeneous, whereas in primed cells, we detected two separate populations, which is also confirmed with flow cytometry (<xref ref-type="fig" rid="F1">Fig. 1D</xref>). Interestingly, immunostaining of Lef1 in naïve ES cells exhibited a clearly heterogenous pattern (including larger colonies, <xref ref-type="supplementary-material" rid="SD1">Fig. S1A</xref>), which becomes homogenous in primed cells (<xref ref-type="fig" rid="F1">Fig. 1C</xref> and <xref ref-type="supplementary-material" rid="SD1">S1B</xref>). Flow cytometry faithfully captured these populations (<xref ref-type="fig" rid="F1">Fig. 1D</xref>), confirming a significant increase in the number of Lef1<sup>+</sup> cells in primed pluripotent conditions (<xref ref-type="fig" rid="F1">Fig. 1E</xref>). Our observations align with previously reported expression of TCF/LEF genes in mouse naïve ES cells (<xref ref-type="bibr" rid="R41">Kelly et al., 2011</xref>; <xref ref-type="bibr" rid="R69">Moreira et al., 2017</xref>; <xref ref-type="bibr" rid="R104">Wallmen et al., 2012</xref>) and go beyond with this interesting novel observation of heterogenous Lef1 expression using immunofluorescence microscopy.</p><p id="P7">Expression of TCF/LEF factors in human naïve and primed pluripotent stem cells differ from those of mouse (<xref ref-type="fig" rid="F1">Fig.1F</xref>). Immunostaining revealed low and heterogeneous presence of both TCF7 and TCF7L2 protein in naïve human pluripotent cells (HNES) cultured routinely in PXGL (<underline><bold>P</bold></underline>D03, <underline><bold>X</bold></underline>AV939, <underline><bold>G</bold></underline>ö6983 and <underline><bold>L</bold></underline>IF) on feeders (<xref ref-type="fig" rid="F1">Fig. 1F</xref>), with a sizable population of TCF7L2<sup>+</sup> cells also detected using flow cytometry (~40%) (<xref ref-type="fig" rid="F1">Fig. 1G</xref>). Further examination of TCF7L2 protein localisation confirmed a heterogenous profile in all cell lines examined: embryo-derived HNES1, HNES3 (<xref ref-type="bibr" rid="R27">Guo et al., 2016</xref>), chemically reset H9 (<xref ref-type="bibr" rid="R26">Guo et al., 2017</xref>) and a naïve induced pluripotent stem cell line (NIPSC3) (<xref ref-type="bibr" rid="R12">Bredenkamp et al., 2019</xref>)(<xref ref-type="supplementary-material" rid="SD1">Fig. S1C</xref>). TCF7L1 was largely absent except for a very small population (~10%) with low expression and LEF1 was undetectable (<xref ref-type="fig" rid="F1">Fig. 1G</xref>). We also assayed TCF/LEF expression in HNES cells cultured briefly under feeder-free conditions. Geltrex was either spiked in (added directly to media) at passaging or precoated on plates. HNES cells cultured on either feeders or when Geltrex was added at plating maintained their characteristic dome-shaped morphology, whereas on Geltrex-coated plates, colonies collapsed with large patches of epithelialisation (<xref ref-type="supplementary-material" rid="SD1">Fig. S1D</xref>). RT-qPCR of key naïve markers, such as <italic>KLF4</italic> and <italic>TCFP2L1</italic>, remain unchanged with only a small increase in <italic>KLF17, SUSD2, DPPA3, NANOG</italic> and <italic>OCT4</italic> levels when plated feeder free (Geltrex, spiked) (<xref ref-type="supplementary-material" rid="SD1">Fig. S1E</xref>). TCF/LEF expression remained largely unchanged with only a small increase in <italic>TCF7</italic> (Geltrex, spiked) and <italic>TCF7L2</italic> (Geltrex, coated) when compared to cells cultured on feeders (<xref ref-type="supplementary-material" rid="SD1">Fig. S1F</xref>). Immunostaining of naïve ES cells on feeders vs Geltrex conditions confirmed homogenous expression of TFCP2L1 with no visible changes in TCF7 and TCF7L2 expression (<xref ref-type="supplementary-material" rid="SD1">Fig. S1G</xref>).</p><p id="P8">Next, we investigated the expression of the TCF/LEF factors in primed human ES cells (Established H9 and capacitated HNES1 and HNES3 human naïve ES cells). When cultured routinely in commercial StemFlex medium or AFX (primed pluripotent conditions), we observed homogenous levels of nuclear-localised TCF7L1 and TCF7L2 (<xref ref-type="fig" rid="F1">Fig. 1F</xref>). At a population-wide level, TCF7L1 expression was generally higher and more homogenous than that of TCF7L2 (<xref ref-type="fig" rid="F1">Fig. 1 G-H</xref>), corroborating previous observations (<xref ref-type="bibr" rid="R87">Sierra et al., 2018</xref>). In stark contrast to mouse primed cells however, we detected very low TCF7 and LEF1 was undetectable (<xref ref-type="fig" rid="F1">Fig. 1F</xref>), supported by flow cytometric analysis (<xref ref-type="fig" rid="F1">Fig. 1G and H</xref>).</p><p id="P9">Taken together, these data clearly demonstrate distinct expression patterns for the TCF/LEF factors between mouse and human pluripotent stem cells, which may account for their differing requirements of WNT signalling for maintaining a naïve pluripotent state (<xref ref-type="bibr" rid="R26">Guo et al., 2017</xref>; <xref ref-type="bibr" rid="R93">Takashima et al., 2014</xref>; <xref ref-type="bibr" rid="R113">Ying et al., 2008</xref>). These differences between human and the mouse paradigm in the expression of TCF/LEF in naïve and primed states of pluripotency motivate and encourage a more detailed analysis in human cells of TCF/LEF expression in differentiation of extraembryonic and embryonic lineages.</p></sec><sec id="S4"><title>TCF/LEF expression in hypoblast cells</title><p id="P10">To study TCF/LEF factor expression in human hypoblast development, we utilised a reproducible and simple 2D differentiation protocol suitable for HNES routinely cultured in PXGL (<xref ref-type="bibr" rid="R15">Dattani et al., 2024</xref>, and <xref ref-type="fig" rid="F2">Fig.2A</xref>). Cells were sequentially switched from 24 hours in PDA83 to 48 hours in FGF4, A8301 and XAV939. After 72 hours, patches of epithelised cells emerged surrounding small refractile colonies (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). Immunostaining confirmed co-expression of the hypoblast markers PDGFRA and SOX17 and not in naïve ES cells (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). Downregulation of naïve pluripotency markers <italic>KLF17, NANOG</italic> and <italic>OCT4</italic> and an upregulation of <italic>GATA6, GATA4</italic> and <italic>SOX17</italic>, including the hypoblast-specific markers <italic>PDGFRA</italic> and <italic>APOA1</italic>, was validated using RT-qPCR (<xref ref-type="fig" rid="F2">Fig. 2C</xref>), confirming a hypoblast identity. Further qRT-PCR analysis showed a strong upregulation of <italic>TCF7L2</italic>, whilst <italic>TCF7L1</italic> and <italic>LEF1</italic> remained unchanged and <italic>TCF7</italic> was reduced in hypoblast cells compared to naïve cells (<xref ref-type="fig" rid="F2">Fig. 2D</xref>). Immunostaining of hypoblast cells indicated TCF7L2 expression was low in PDGFRA<sup>+</sup>/SOX17<sup>+</sup> cells and more prominent in a population of cells that do not express PDGFRA or SOX17 (<xref ref-type="fig" rid="F2">Fig. 2E</xref>). This observation suggests a persistent population of cells expressing TCF7L2, which may represent trophectoderm, an alternative cell type also specified with this protocol (<xref ref-type="bibr" rid="R15">Dattani et al., 2024</xref>). Flow cytometry confirmed a small percentage of cells expressing GATA4<sup>+</sup> hypoblast cells (~28%) after 72 hours in differentiation conditions (<xref ref-type="fig" rid="F2">Fig. 2F</xref>), which largely corroborated our immunostaining observations. Of note, a very small population of GATA4<sup>+</sup>/LEF1<sup>+</sup> cells were detected accounting for 2.5-3.5% of the total population (<xref ref-type="fig" rid="F2">Fig.2F</xref>).</p><p id="P11">Human naïve pluripotent cells treated with ACTIVIN A, CHIR99021 and LIF (ACL) for 5-6 days generate naïve primitive endoderm (nEND)(<xref ref-type="bibr" rid="R52">Linneberg-Agerholm et al., 2019</xref>) or yolk sac-like cells (<xref ref-type="bibr" rid="R60">Mackinlay et al., 2021</xref>), which appear to represent different stages of hypoblast development in the human embryo. Therefore, we compared TCF/LEF factor and key marker gene expression between hypoblast and nEND. When naïve ES cells were exposed to ACL for 5-6 days, naïve colonies collapsed and widespread epithelialisation was observed (<xref ref-type="supplementary-material" rid="SD1">Fig. S2A</xref>). We then utilised RT-qPCR to quantify mRNA transcripts between each culture condition (<xref ref-type="supplementary-material" rid="SD1">Fig. S2B</xref>). <italic>KLF17, NANOG</italic> and <italic>OCT4</italic> expression was all strongly reduced in nEND cells, and less strongly in hypoblast cells, corroborating previous reports (<xref ref-type="bibr" rid="R15">Dattani et al., 2024</xref>; <xref ref-type="bibr" rid="R52">Linneberg-Agerholm et al., 2019</xref>). Whilst <italic>GATA6</italic> and <italic>GATA4</italic> remained relatively unchanged between each culture condition, we observed much higher levels of <italic>PDGFRA</italic> and <italic>APOA1</italic> in hypoblast cells. <italic>SOX17</italic> was undetectable in nEND cells, which, interestingly, also express elevated levels of the mesoderm marker <italic>ALPNR</italic> (<xref ref-type="bibr" rid="R36">Jackson et al., 2021</xref>; <xref ref-type="bibr" rid="R50">Lam et al., 2023</xref>; <xref ref-type="bibr" rid="R86">Sagrac et al., 2020</xref>)(<xref ref-type="supplementary-material" rid="SD1">Fig. S2B</xref>). Further analysis revealed <italic>TCF7L2</italic> was clearly increased in hypoblast cultures, whereas <italic>TCF7, LEF1</italic> and <italic>TCF7L1</italic> were highly expressed in nEND, demonstrating a key difference in these cell populations (<xref ref-type="supplementary-material" rid="SD1">Fig. S2C</xref>). Immunostaining of hypoblast and nEND cells confirmed TCF7 in both GATA4<sup>+</sup> and NANOG<sup>+</sup> nuclei while LEF1 was restricted to GATA4<sup>+</sup> nEND cells, and TCF7L1 was co-expressed with nests of NANOG<sup>+</sup> pluripotent cells (<xref ref-type="supplementary-material" rid="SD1">Fig. S2D</xref>).</p></sec><sec id="S5"><title>Trophectoderm cells express high TCF7L2</title><p id="P12">Human naïve pluripotent cells can differentiate into trophectoderm cells in differentiation medium PDA83, containing PD03 (a MEK/ERK inhibitor) and A8301 (a potent TGFβ/NODAL inhibitor) (<xref ref-type="bibr" rid="R25">Guo et al., 2021</xref>; <xref ref-type="bibr" rid="R34">Io et al., 2021</xref>). HNES cells were plated onto Geltrex-coated plates and switched to PDA83 for 72 hours (<xref ref-type="fig" rid="F3">Fig. 3A</xref>). Characteristic patches of epithelialised cells emerged and immunostaining of GATA3 expression and absence of NANOG confirmed differentiation (<xref ref-type="fig" rid="F3">Fig. 3B</xref>). <italic>KLF17, NANOG</italic> and <italic>OCT4</italic> mRNA levels decreased over 72 hours in PDA83 with a concomitant strong increase in expression of the trophectoderm markers <italic>GATA3, GATA2</italic> and <italic>CDX2</italic> (<xref ref-type="fig" rid="F3">Fig. 3C</xref>). When analysing TCF/LEF expression with RT-qPCR (<xref ref-type="fig" rid="F3">Fig.3D</xref>), we observed reduced levels of <italic>TCF7</italic>, no apparent changes in <italic>LEF1</italic> and a strong increase in <italic>TCF7L2</italic> expression. Immunostaining of trophectoderm cultures at 72 hours (<xref ref-type="fig" rid="F3">Fig. 3E</xref>) confirmed our initial RT-qPCR observations, including low and heterogeneous TCF7L1/GATA3<sup>+</sup> cells (white arrows) and largely homogenous TCF7L2 nuclear localisation in both NANOG<sup>+</sup> and GATA3<sup>+</sup> cells. A small population of TCF7L1/GATA3<sup>+</sup> cells (~20%) and two populations of cells expressing TCF7L2 with GATA3 (~53%) and without (~16%) were present in these cultures (<xref ref-type="fig" rid="F3">Fig. 3F</xref>).</p></sec><sec id="S6"><title>WNT/β-Catenin signalling induces TCF7 and LEF1 in primed cells</title><p id="P13">WNT/β-Catenin signalling is essential for the initiation of gastrulation and subsequently the differentiation of mesendoderm cells into mesodermal and endodermal subtypes (<xref ref-type="bibr" rid="R5">Barrow et al., 2007</xref>; <xref ref-type="bibr" rid="R8">Biechele et al., 2013</xref>; <xref ref-type="bibr" rid="R56">Liu et al., 1999</xref>). We have established that human primed pluripotent stem cells only express TCF7L1 and TCF7L2, but neither TCF7 nor LEF1 (<xref ref-type="fig" rid="F1">Fig.1D</xref>), which is in agreement with previous observations (<xref ref-type="bibr" rid="R87">Sierra et al., 2018</xref>) and in stark contrast to mouse primed cells (<xref ref-type="fig" rid="F1">Fig.1C</xref>). We then asked whether activation of WNT/β-Catenin signalling (initiating mesendoderm differentiation) would alter TCF/LEF expression. Human primed pluripotent stem cells were treated with either CHIR or WNT3A for 24 hours. Indeed, upon CHIR or WNT3A treatment, colonies of hPSCs formed domes with refractile edges (<xref ref-type="fig" rid="F4">Fig. 4A</xref>) and β-Catenin was localised to the nuclei of cells (<xref ref-type="fig" rid="F4">Fig. 4B</xref>, compare inserts b1 with b2; <xref ref-type="supplementary-material" rid="SD1">Fig. S3A</xref>). Concomitant with a change in cell morphology, β-Catenin was present in the nuclei of CHIR-treated but not control or IWP2-treated hPSCs, similarly to previous reports in hPSCs (<xref ref-type="bibr" rid="R18">Dziedzicka et al., 2021</xref>; <xref ref-type="bibr" rid="R65">Massey et al., 2019</xref>; <xref ref-type="bibr" rid="R87">Sierra et al., 2018</xref>), colorectal cancer cells (<xref ref-type="bibr" rid="R1">Ambrosi et al., 2022</xref>) and HEK293T cells (<xref ref-type="bibr" rid="R39">Kafri et al., 2016</xref>). To monitor activation of the WNT/β-Catenin pathway, we measured expression of the WNT target gene <italic>AXIN2</italic> (<xref ref-type="bibr" rid="R38">Jho et al., 2002</xref>), which confirmed a strong upregulation when hPSCs were treated with CHIR and to a lesser extent with recombinant WNT3A protein (<xref ref-type="fig" rid="F4">Fig. 4C</xref> and S3B). Furthermore, immunostaining established the presence of widespread and homogenous BRACHYURY protein localisation (<xref ref-type="fig" rid="F4">Fig. 4D</xref>), with concomitant increased levels of <italic>TBXT, MIXL1</italic> and <italic>EOMES</italic> mRNA; strongly when treated with CHIR (<xref ref-type="fig" rid="F4">Fig. 4E</xref>) and more modestly with WNT3A recombinant protein (<xref ref-type="supplementary-material" rid="SD1">Fig. S3B</xref>). Upon differentiation, the expression profiles of all four TCF/LEF genes changed dramatically, with both <italic>TCF7L1</italic> and <italic>TCF7L2</italic> being strongly reduced alongside an increase in <italic>TCF7</italic> and <italic>LEF1</italic> mRNA levels (<xref ref-type="fig" rid="F4">Fig. 4F</xref>). There was a more pronounced effect on the expression of the TCF/LEF factors with CHIR than WNT3A, with only a small increase in <italic>TCF7</italic> and <italic>LEF1</italic> and decrease of <italic>TCF7L1</italic> and <italic>TCF7L2</italic> (<xref ref-type="supplementary-material" rid="SD1">Fig. S3C</xref>). Immunostaining of TCF/LEF expression in control and treated hPSCs largely corroborated our initial observations with RT-qPCR (<xref ref-type="fig" rid="F4">Fig. 4G</xref> and S3D). Interestingly, we observed LEF1<sup>+</sup> nuclei around the edge of the colony following WNT3A only (<xref ref-type="supplementary-material" rid="SD1">Fig. S3D</xref>), similarly to a previous report using micropattern gastruloids (<xref ref-type="bibr" rid="R64">Martyn et al., 2019</xref>). Finally, flow cytometric analysis of CHIR-treated hPSCs demonstrated a strong increase in both TCF7<sup>+</sup> (~82%) and LEF1<sup>+</sup> (~93%) cells whilst TCF7L1- and TCF7L2-expressing cell numbers were slightly decreased (<xref ref-type="fig" rid="F4">Fig. 4H and 4I</xref>). Of note, despite the total number of gated cells increasing only slightly, there was an observable shift in their overall intensity (<xref ref-type="fig" rid="F4">Fig. 4H</xref>).</p><p id="P14">Collectively, these results on TCF/LEF expression in human cells clearly differ from the mouse paradigm. In human primed pluripotent cells, we show that alongside <italic>LEF1</italic> (<xref ref-type="bibr" rid="R21">Funa et al., 2015</xref>; <xref ref-type="bibr" rid="R64">Martyn et al., 2019</xref>), <italic>TCF7</italic> is also upregulated in response to active WNT signalling. Moreover, both <italic>TCF7L1</italic> and <italic>TCF7L2</italic> are subsequently downregulated as differentiation ensues to control the spatiotemporal expression of mesendoderm genes (<xref ref-type="bibr" rid="R29">Hoffman et al., 2013</xref>; <xref ref-type="bibr" rid="R87">Sierra et al., 2018</xref>).</p></sec><sec id="S7"><title>TCF7L1 and TCF7L2 expression persists in amnion cells</title><p id="P15">Activation of BMP signalling in human primed pluripotent stem cells has been reported to induce their differentiation into either trophoblast (<xref ref-type="bibr" rid="R2">Amita et al., 2013</xref>; <xref ref-type="bibr" rid="R81">Roberts et al., 2014</xref>; <xref ref-type="bibr" rid="R109">Xu et al., 2002</xref>; <xref ref-type="bibr" rid="R110">Yabe et al., 2016</xref>) or amnion cells (<xref ref-type="bibr" rid="R25">Guo et al., 2021</xref>; <xref ref-type="bibr" rid="R34">Io et al., 2021</xref>; <xref ref-type="bibr" rid="R84">Rostovskaya et al., 2022</xref>). The embryonic relationship between these tissues remains an area of controversy but recent data suggest that primed hPSCs generate amnion, whereas naïve human embryonic stem cells give rise to trophectoderm (<xref ref-type="bibr" rid="R25">Guo et al., 2021</xref>; <xref ref-type="bibr" rid="R34">Io et al., 2021</xref>; <xref ref-type="bibr" rid="R84">Rostovskaya et al., 2022</xref>). We treated human primed ES cells with dual FGF and NODAL inhibition alongside BMP4 to induce amnion differentiation. After 72 hours, large sheets of flattened epithelial cells emerged (<xref ref-type="fig" rid="F5">Fig. 5A</xref>), which were GATA3<sup>+</sup> and NANOG<sup>-</sup> (<xref ref-type="fig" rid="F5">Fig. 5B</xref>). <italic>NANOG</italic> and <italic>OCT4</italic> expression levels decreased and <italic>GATA3, GATA2, TFAP2A</italic> and <italic>IGFBP5</italic> were strongly increased (<xref ref-type="fig" rid="F5">Fig. 5C</xref>), denoting entry into the amnion lineage. Both <italic>TCF7</italic> and <italic>TCF7L1</italic> were decreased, <italic>TCF7L2</italic> was strongly increased and <italic>LEF1</italic> remained unchanged (<xref ref-type="fig" rid="F5">Fig. 5D</xref>). Immunostaining on control and differentiated cells revealed no visible differences in TCF7, LEF1 and TCF7L1 expression, however, TCF7L2 staining appeared diminished (<xref ref-type="fig" rid="F5">Fig. 5E</xref>). Flow cytometry confirmed a strong decrease in the total number of gated TCF7L2<sup>+</sup> cells and less homogenous expression than in control hPSCs (<xref ref-type="fig" rid="F5">Fig. 5F and G</xref>), despite an increase in mRNA levels (<xref ref-type="fig" rid="F5">Fig. 5C</xref>). Delays in protein turnover compared to relative mRNA levels could account for these differences.</p><p id="P16">These data suggest that the persistence of TCF7L1 and TCF7L2 expression may be an important prerequisite, defining an epiblast-amnion boundary for primate amnion development (<xref ref-type="bibr" rid="R7">Bergmann et al., 2022</xref>; <xref ref-type="bibr" rid="R84">Rostovskaya et al., 2022</xref>) and to shield against active WNT/β-Catenin signalling induced by BMP4 signalling (<xref ref-type="bibr" rid="R64">Martyn et al., 2019</xref>; <xref ref-type="bibr" rid="R114">Yoney et al., 2022</xref>).</p></sec><sec id="S8"><title>Temporal expression of the TCF/LEF factors in definitive endoderm</title><p id="P17">Shortly following the formation of the primitive streak and mesendoderm cells in the mammalian embryo (<xref ref-type="bibr" rid="R80">Rivera-Perez and Magnuson, 2005</xref>), fine-tuning of BMP, NODAL, WNT and FGF signalling facilitates further differentiation in mesodermal subtypes and definitive endoderm (<xref ref-type="bibr" rid="R4">Bardot and Hadjantonakis, 2020</xref>; <xref ref-type="bibr" rid="R7">Bergmann et al., 2022</xref>; <xref ref-type="bibr" rid="R94">Tam and Behringer, 1997</xref>; <xref ref-type="bibr" rid="R101">Tyser et al., 2021</xref>). We leveraged a robust protocol to efficiently differentiate primed pluripotent cells in a stepwise fashion towards definitive endoderm cells (<xref ref-type="bibr" rid="R58">Loh et al., 2014</xref>) and subsequently profiled the expression of the TCF/LEF factors. Human primed ES cells were treated with signalling modulators over 72 hours, which gave rise to a monolayer of epithelial cells (<xref ref-type="fig" rid="F6">Fig. 6A</xref>). Whilst SOX17 was widely detectable, NANOG was lost (<xref ref-type="fig" rid="F6">Fig. 6B</xref>). Pluripotency makers <italic>NANOG</italic> and <italic>OCT4</italic> were downregulated and canonical endoderm markers <italic>SOX17, CXCR4, FGF17</italic> and <italic>CER1</italic> were strongly increased at 72 hours, which was confirmed using RT-qPCR (<xref ref-type="fig" rid="F6">Fig. 6C</xref>). Further analysis revealed no significant changes in <italic>LEF1</italic>, however, TCF7 was increased and both <italic>TCF7L1</italic> and <italic>TCF7L2</italic> were lower than in control primed ES cells (<xref ref-type="fig" rid="F6">Fig. 6D</xref>). Immunostaining confirmed widespread SOX17<sup>+</sup> endoderm cells with visible TCF7, TCF7L1, TCF7L2 signal and no detectable expression of LEF1 (<xref ref-type="fig" rid="F6">Fig. 6E</xref>). Flow cytometric analysis revealed a population of TCF7<sup>+</sup> cells (~51%), TCF7L1<sup>+</sup> decreased (~45%) and whilst the total numbers of TCF7L2<sup>+</sup> exhibited no significant difference, the overall intensity of this signal shifted (<xref ref-type="fig" rid="F6">Fig. 6F</xref>). These observations were consistent over three independent cell lines in our hands (<xref ref-type="fig" rid="F6">Fig. 6G</xref>, but also see recently published observations by <xref ref-type="bibr" rid="R70">Mukherjee et al. (2022)</xref>)</p><p id="P18">These findings suggest that both TCF7 and LEF1 exhibit temporal activity whereby their expression decreases over time during definitive endoderm commitment following upregulation in hPSCs after WNT stimulation. Moreover, despite the strong decreases in the mRNA levels of <italic>TCF7L1</italic> and <italic>TCF7L2</italic> in SOX17<sup>+</sup> endoderm, their expression suggests a role in maintaining lineage identity, preventing precocious and differentiation into other cell types.</p></sec></sec><sec id="S9" sec-type="discussion"><title>Discussion</title><p id="P19">Our current understanding regarding the roles of WNT signalling underpinning early mammalian development and stem cell biology has been predominantly informed from genetic studies in rodent models. However, applying this rodent paradigm to early human development has become increasingly difficult. Here, we leveraged mouse and human pluripotent stem cell models to test conservation of expression and localisation of TCF7, LEF1, TCF7L1 and TCF7L2, the canonical terminal effectors of the WNT/β-Catenin pathway (<xref ref-type="fig" rid="F7">Fig.7</xref>).</p><sec id="S10"><title>Differences in states of pluripotency</title><p id="P20">We show that mouse and human comprehensively differ in expression of TCF/LEF factors in what is currently widely considered comparative states of naïve and primed pluripotency (<xref ref-type="fig" rid="F1">Fig. 1</xref>). We confirm in mouse naïve ES culture the expression of all four TCF/LEF genes but find only low levels of <italic>TCF7</italic> and <italic>TCF7L2</italic> in human naïve pluripotency. It is interesting to find heterogeneous LEF1 expression in the mouse (<xref ref-type="fig" rid="F1">Fig. 1C</xref>); since LEF1 expression is known to increase upon release from naïve pluripotency (<xref ref-type="bibr" rid="R111">Ye et al., 2017</xref>).</p><p id="P21">Rat naïve ES cells appear to express higher <italic>Lef1</italic> than mouse naïve ES cells and knockdown of Lef1 (<xref ref-type="bibr" rid="R14">Chen et al., 2013</xref>) or TALEN-mediated mutagenesis (<xref ref-type="bibr" rid="R67">Meek et al., 2020</xref>) can effectively counteract precocious differentiation associated with higher concentrations of CHIR. In mouse primed pluripotent stem cells (i.e., EpiSCs, <xref ref-type="fig" rid="F1">Fig. 1C-E</xref>), we detect homogenous Lef1 expression, mirroring E7.5 stage embryos (<xref ref-type="bibr" rid="R24">Galceran et al., 2001</xref>; <xref ref-type="bibr" rid="R75">Oosterwegel et al., 1993</xref>). In our hands, we could not detect LEF1 in 5 different human primed ES/iPS cell lines (<xref ref-type="fig" rid="F1">Fig. 1F-H</xref>, see also <xref ref-type="fig" rid="F4">Fig.4F</xref>), although <xref ref-type="bibr" rid="R60">Mackinlay et al. (2021)</xref> have reported stronger LEF1 staining, which may be due to different culturing conditions or detection methods and likely reflects different levels of endogenous WNT signalling. Homogeneous LEF1 in mouse primed cells but not human might account for their hypersensitivity to WNT signalling. Blocking WNT signalling with either IWP2 or XAV939/IWR1 improves the derivation efficiency and long-term propagation of mouse primed cells from postimplantation embryos (<xref ref-type="bibr" rid="R55">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="R89">Sugimoto et al., 2015</xref>; <xref ref-type="bibr" rid="R90">Sumi et al., 2013</xref>). Similarly, this approach has successfully facilitated the derivation of stable primed pluripotent stem cells from preimplantation blastocysts of pig, sheep and cow with XAV939 (<xref ref-type="bibr" rid="R45">Kinoshita et al., 2021b</xref>). Interestingly, combined XAV939 and IWP2 (to tightly suppress WNT signalling) was shown to derive stable rat (<xref ref-type="bibr" rid="R35">Iwatsuki et al., 2023</xref>) and rabbit (<xref ref-type="bibr" rid="R46">Kobayashi et al., 2021</xref>) primed ES cells. Finally, the inclusion of XAV939 but not CHIR captures chimera-competent ES-like cells from isolated chicken blastoderm discs (<xref ref-type="bibr" rid="R40">Kajihara et al., 2024</xref>). Taken together, we propose that the blockade of WNT/β-Catenin signalling in primed pluripotent cells universally serves as an important prerequisite to 1) maintain uniformity, 2) prevent premature differentiation and 3) ensure efficient directed differentiation.</p><p id="P22">These species-specific variations in TCF/LEF expression are likely related to the revealed different requirements for WNT/β-catenin signalling between mouse and human for stable propagation of the naïve pluripotent state (<xref ref-type="bibr" rid="R6">Bayerl et al., 2021</xref>; <xref ref-type="bibr" rid="R12">Bredenkamp et al., 2019</xref>; <xref ref-type="bibr" rid="R26">Guo et al., 2017</xref>; <xref ref-type="bibr" rid="R59">Lyashenko et al., 2011</xref>; <xref ref-type="bibr" rid="R93">Takashima et al., 2014</xref>; <xref ref-type="bibr" rid="R106">Wray et al., 2011</xref>; <xref ref-type="bibr" rid="R113">Ying et al., 2008</xref>). Culture conditions mirroring the 2i+LIF from mouse were initially found to be unsuitable for stable propagation of human naïve ES/iPS cells (<xref ref-type="bibr" rid="R22">Gafni et al., 2013</xref>; <xref ref-type="bibr" rid="R28">Hanna et al., 2010</xref>; <xref ref-type="bibr" rid="R93">Takashima et al., 2014</xref>). Significantly, 2i+LIF leads to strong activation of WNT signalling (via CHIR99021). Fine-tuning the concentration of CHIR drastically improves the propagation of both human (<xref ref-type="bibr" rid="R93">Takashima et al., 2014</xref>; <xref ref-type="bibr" rid="R96">Theunissen et al., 2014</xref>) and rat naïve ES cells (<xref ref-type="bibr" rid="R14">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="R68">Meek et al., 2013</xref>). More recently, it has been shown that exchanging CHIR with a potent TANKYRASE inhibitor, XAV939 (initially described as a Wnt inhibitor, <xref ref-type="bibr" rid="R33">Huang et al., 2009</xref>), boosts self-renewal of human naïve ES cells (<xref ref-type="bibr" rid="R6">Bayerl et al., 2021</xref>; <xref ref-type="bibr" rid="R12">Bredenkamp et al., 2019</xref>; <xref ref-type="bibr" rid="R26">Guo et al., 2017</xref>; <xref ref-type="bibr" rid="R42">Khan et al., 2021</xref>; <xref ref-type="bibr" rid="R116">Zimmerlin et al., 2016</xref>), by predominantly buffering HIPPO signalling (<xref ref-type="bibr" rid="R16">Dattani et al., 2022</xref>). HNES cells lacking β-Catenin protein can self-renew and express key naïve pluripotent markers, implying that activation of the WNT/β-catenin pathway might be largely dispensable for supporting human naïve pluripotency (<xref ref-type="bibr" rid="R6">Bayerl et al., 2021</xref>; <xref ref-type="bibr" rid="R16">Dattani et al., 2022</xref>). However, we cannot rule out the possibility of compensatory mechanisms from Plakoglobin, a homologue of β-Catenin (<xref ref-type="bibr" rid="R61">Mahendram et al., 2013</xref>). Recently, it had been shown to boost naïve pluripotency in mouse ES cells and is expressed in the epiblast of early human embryos and naïve ES cells but not primed cells (<xref ref-type="bibr" rid="R47">Kohler et al., 2023</xref>).</p><p id="P23">Low <italic>TCF7L1</italic> expression in human naïve pluripotency raises several fundamental and exciting questions regarding its role in the regulation of pluripotency in mammals. Despite its very low expression in naïve ES cells, <italic>TCF7L1</italic> expression gradually increases as cells undergo capacitation (transitioning from naïve to primed pluripotency)(<xref ref-type="bibr" rid="R85">Rostovskaya et al., 2019</xref>) and is homogenously expressed in primed ES cells (<xref ref-type="fig" rid="F1">Fig. 1F-H</xref>)(see also <xref ref-type="bibr" rid="R87">Sierra et al., 2018</xref>). These lower levels of TCF7L1 may contribute to the unrestricted lineage potential of human naïve ES cells (<xref ref-type="bibr" rid="R15">Dattani et al., 2024</xref>; <xref ref-type="bibr" rid="R25">Guo et al., 2021</xref>; <xref ref-type="bibr" rid="R52">Linneberg-Agerholm et al., 2019</xref>), even though Tcf7l1 does not restrict the differentiation of mouse naïve ES cells towards primitive endoderm (<xref ref-type="bibr" rid="R3">Athanasouli et al., 2023</xref>). Given its primary role as a strong repressor of gene expression (<xref ref-type="bibr" rid="R43">Kim et al., 2000</xref>; <xref ref-type="bibr" rid="R54">Liu et al., 2005</xref>; <xref ref-type="bibr" rid="R112">Yi et al., 2011</xref>), TCF7L1 fundamentally functions to tightly control differentiation and other signalling pathways, one of which is NODAL (<xref ref-type="bibr" rid="R87">Sierra et al., 2018</xref>). Human naïve and primed pluripotent cells require active NODAL signalling and its inhibition downregulates key pluripotency markers such as <italic>NANOG</italic> (<xref ref-type="bibr" rid="R37">James et al., 2005</xref>; <xref ref-type="bibr" rid="R76">Osnato et al., 2021</xref>; <xref ref-type="bibr" rid="R102">Vallier et al., 2005</xref>). When both NODAL and MEK-ERK signalling are blocked simultaneously, naïve ES cells readily undergo trophectoderm differentiation (<xref ref-type="bibr" rid="R25">Guo et al., 2021</xref>; <xref ref-type="bibr" rid="R34">Io et al., 2021</xref>). Conversely, in primed cells, TCF7L1 acts as a rheostat for a plethora of key gastrulation genes and its knockdown drastically increases <italic>NODAL</italic> expression (<xref ref-type="bibr" rid="R87">Sierra et al., 2018</xref>). Therefore, lower levels of TCF7L1 may permit high <italic>NODAL</italic> expression required for long-term self-renewal of human naïve ES cells. Future experiments will aim to express <italic>TCF7L1</italic> in HNES cells to see if they behave more like mouse naïve ES cells. Furthermore, inhibition of Nodal signalling in mouse ES cells does not impair their self-renewal in a naïve state, however, trilineage differentiation in a primed state is severely compromised (<xref ref-type="bibr" rid="R71">Mulas et al., 2017</xref>).</p><p id="P24">Since we have uncovered fundamental differences in TCF/LEF factor expression in human pluripotent cells between the naïve and primed pluripotent states, a future detailed analysis during capacitation is required. In support of this, the transition for naïve to primed pluripotency has revealed a fundamental requirement for WNT inhibition to circumvent precocious differentiation (<xref ref-type="bibr" rid="R85">Rostovskaya et al., 2019</xref>). Thus, it is of interest to understand how the epiblast transitions between pluripotent states is sufficiently shielded from WNT signalling, which may rely on SFRP family members secreted from the nascent epiblast and hypoblast (<xref ref-type="bibr" rid="R9">Blakeley et al., 2015</xref>; <xref ref-type="bibr" rid="R88">Stirparo et al., 2018</xref>). Furthermore, while we compared mouse and human in what is currently widely considered equivalent stages of pluripotency (naïve and primed), our findings here provide further evidence that they may not be equivalent in mouse and human. While both mouse and human naïve ES cells developmentally recapitulate the preimplantation epiblast of the embryo (<xref ref-type="bibr" rid="R10">Boroviak et al., 2014</xref>; <xref ref-type="bibr" rid="R27">Guo et al., 2016</xref>; <xref ref-type="bibr" rid="R93">Takashima et al., 2014</xref>), Mouse EpiSCs more likely represent a mid-gastrula stage (<xref ref-type="bibr" rid="R44">Kinoshita et al., 2021a</xref>; <xref ref-type="bibr" rid="R48">Kojima et al., 2014</xref>; <xref ref-type="bibr" rid="R95">Tesar et al., 2007</xref>; <xref ref-type="bibr" rid="R99">Tsakiridis et al., 2014</xref>) compared to human primed cells, which closely resemble the pre-gastrula epiblast (<xref ref-type="bibr" rid="R101">Tyser et al., 2021</xref>; <xref ref-type="bibr" rid="R108">Xiang et al., 2020</xref>). Comparative studies investigating the expression profiles of the TCF/LEF across other ES cells from a range of species will provide a wider perspective for understanding the fundamental differences in human development compared to the rodent paradigm. The expression of Tcf7l1 in mouse naïve ES cells and rapid upregulation of Lef1 present in primed cells might also be related to developmental pace. The epiblast of mouse embryos transitions from a naïve state and undergo gastrulation within 48 hours (<xref ref-type="bibr" rid="R72">Nichols and Smith, 2009</xref>). In humans and non-human primate embryos, the equivalent stages can take 7-10 days (<xref ref-type="bibr" rid="R11">Boroviak and Nichols, 2017</xref>; <xref ref-type="bibr" rid="R84">Rostovskaya et al., 2022</xref>; <xref ref-type="bibr" rid="R85">Rostovskaya et al., 2019</xref>). Thus, a lack of TCF7L1 and LEF1 expression in human naïve pluripotency may permit a longer periimplantation period required for specifying extraembryonic mesoderm and amnion, both of which emerge following gastrulation during mouse embryogenesis (<xref ref-type="bibr" rid="R11">Boroviak and Nichols, 2017</xref>; <xref ref-type="bibr" rid="R83">Ross and Boroviak, 2020</xref>).</p></sec><sec id="S11"><title>Extraembryonic and early embryonic cell lineages</title><p id="P25">Comparing hypoblast cells (<xref ref-type="bibr" rid="R15">Dattani et al., 2024</xref>) with nEND cells (naïve Endoderm, <xref ref-type="bibr" rid="R52">Linneberg-Agerholm et al., 2019</xref>) reveals clear differences in that hypoblast cells express only low levels of TCF7L2, whereas nEND differentiation upregulates both <italic>TCF7</italic> and <italic>LEF1</italic>. Interestingly, following the nEND protocol, we detected the upregulation of <italic>APLNR</italic>, usually considered a key mesoderm receptor involved in cardiac development (<xref ref-type="bibr" rid="R36">Jackson et al., 2021</xref>; <xref ref-type="bibr" rid="R50">Lam et al., 2023</xref>; <xref ref-type="bibr" rid="R86">Sagrac et al., 2020</xref>). Moreover, we observed a very small fraction of GATA4/LEF1<sup>+</sup> cells following hypoblast differentiation (<xref ref-type="bibr" rid="R15">Dattani et al., 2024</xref>). Although the embryonic origin of the extraembryonic mesoderm (ExMe) remains unclear, a hypoblast origin in the peri-implantation primate embryo has recently been proposed (<xref ref-type="bibr" rid="R83">Ross and Boroviak, 2020</xref>). The observed low population of GATA4/LEF1<sup>+</sup> cells may therefore represent ExMe differentiation from the hypoblast. Consistent with this notion, data analysis from <xref ref-type="bibr" rid="R7">Bergmann et al. (2022)</xref> shows high <italic>LEF1</italic> expression in cells demarcated to be ExMe from single cell RNA-seq data of peri/postimplantation marmoset embryos. Moreover, cells resembling ExMe have been derived from human naïve pluripotent cells (<xref ref-type="bibr" rid="R74">Oldak et al., 2023</xref>; <xref ref-type="bibr" rid="R77">Pham et al., 2022</xref>) with culture conditions containing WNT-pathway activating CHIR. Taken together, our comparative data suggest that different culture conditions induce separate populations of differentiated cells that are reminiscent of hypoblast cells, representative of early and later stages, respectively (<xref ref-type="bibr" rid="R15">Dattani et al., 2024</xref>; <xref ref-type="bibr" rid="R52">Linneberg-Agerholm et al., 2019</xref>; <xref ref-type="bibr" rid="R60">Mackinlay et al., 2021</xref>). These differences in culture conditions could account for the contrasting TCF/LEF expression patterns in our current observations and might be related to the status of endogenous WNT signalling (i.e., WNT activation in nEND and inhibition in hypoblast cells).</p><p id="P26">Strikingly, we observed high levels of TCF7L2 in trophectoderm cells derived directly from human naïve pluripotent stem cells. TCF7L2 has known functional links to regulation of metabolism (e.g., <xref ref-type="bibr" rid="R103">Verma et al., 2022</xref>), controlling context-specific cell differentiation (e.g., <xref ref-type="bibr" rid="R53">Lipiec et al., 2020</xref>) and proliferation (e.g., <xref ref-type="bibr" rid="R105">Wenzel et al., 2020</xref>). Moreover, this gene encodes alternatively spliced isoforms (reviewed by <xref ref-type="bibr" rid="R32">Hoppler and Waterman, 2014</xref>; and in <xref ref-type="bibr" rid="R98">Torres-Aguila et al., 2022</xref>) that contribute to this diverse functionality of TCF7L2 (e.g., <xref ref-type="bibr" rid="R115">Young et al., 2019</xref>). By controlling trophoblast cell differentiation, TCF7L2 may have ultimately a role in human embryo implantation. Intriguingly, the WNT inhibitor DKK1 is upregulated in the endometrium of women who have been hyper-stimulated with oestrogen/progesterone prior to egg collection, thereby reducing pregnancy rates (<xref ref-type="bibr" rid="R57">Liu et al., 2010</xref>). These increased levels of DKK1 may disrupt the embryonic-endometrial interface that is required normally to facilitate proper implantation. Our results suggest that TCF7L2 is upregulated in response to trophectoderm lineage induction, maybe prior to onset of <italic>GATA3</italic> expression and that heterogenous TCF7L1 expression might reflect a mixture of differentiated trophoblast subtypes (<xref ref-type="bibr" rid="R78">Pollheimer et al., 2006</xref>).</p><p id="P27">Positive feedback regulation of TCF7 and LEF1 following experimental WNT activation in primed human pluripotent stem cells is reminiscent of some other tissues, since these TCF/LEF genes have previously been found to be positively regulated by WNT signalling, for instance in the context of colorectal cancer (<xref ref-type="bibr" rid="R51">Li et al., 2006</xref>; <xref ref-type="bibr" rid="R66">Mayer et al., 2020</xref>; <xref ref-type="bibr" rid="R82">Roose et al., 1999</xref>). Both Tcf7 and Lef1 contribute to paraxial mesoderm development, somite formation and limb development (<xref ref-type="bibr" rid="R23">Galceran et al., 1999</xref>), with mutants phenocopying Wnt3a-null mice (<xref ref-type="bibr" rid="R92">Takada et al., 1994</xref>). Here, we added TCF7 to LEF1 expression induced by active WNT/β-catenin signalling using either CHIR or recombinant WNT3A protein has been described previously (<xref ref-type="bibr" rid="R21">Funa et al., 2015</xref>; <xref ref-type="bibr" rid="R64">Martyn et al., 2019</xref>). Interestingly, forced overexpression of TCF7 but not LEF1 promotes the differentiation of human primed pluripotent stem cells towards an endoderm fate by upregulating key differentiation genes such as <italic>TBXT, MIXL1</italic> and <italic>GATA6</italic> (<xref ref-type="bibr" rid="R91">Sun et al., 2017</xref>). Moreover, knockdown of GATA6 but not GATA4 blocks differentiation mediated by TCF7. TCF7 persistence in the endoderm (albeit at low levels) and no LEF1 in our model suggests a temporal window of induction that may also be lineage-specific and requires further in-depth examination.</p><p id="P28">Our analysis here provides a basis for future experiments to investigate upstream mechanisms of gene regulation of TCF/LEF genes during early human development, comparing it to mouse. This analysis also provides a basis for formulating novel hypotheses about regulation of downstream gene expression by WNT signalling and any possible differences between TCF7-, LEF1-, TCF7L1-, or TCF7L2-mediated downstream gene expression. How these described differences in TCF/LEF deployment between the human and mouse paradigm may account for differences in subsequent gene expression (such as for instance esrrb, <xref ref-type="bibr" rid="R62">Martello et al., 2012</xref>) requires further investigation. This analysis has predominantly focused on genes expression of all four TCF/LEF, however, particularly TCF7 and TCF7L2 are known to encode different mRNA and protein isoforms (<xref ref-type="bibr" rid="R98">Torres-Aguila et al., 2022</xref>), which may fine-tune the transcriptional response to WNT/β-Catenin signalling in early human development.</p></sec><sec id="S12"><title>Limitations of the study</title><p id="P29">Human embryos constitute a precious resource, requires a HFEA licence in the United Kingdom and regulatory approval prior to experimentation. Although our study was performed using pluripotent stem cells and differentiated subtypes, they only represent experimentally accessible models of early human embryogenesis. Therefore, future research will aim to perform immunofluorescence microscopy in early-stage human embryos to confirm these observations. We profiled the expression of the TCF/LEF factors in human naïve pluripotent stem cells routinely cultured in PXGL (<xref ref-type="bibr" rid="R12">Bredenkamp et al., 2019</xref>; <xref ref-type="bibr" rid="R26">Guo et al., 2017</xref>) and did not further explore alternative conditions, such as t2iLiGö (<xref ref-type="bibr" rid="R93">Takashima et al., 2014</xref>) or 5i/LA (<xref ref-type="bibr" rid="R96">Theunissen et al., 2014</xref>) that contain a low concentration of GSK3 inhibitor. CHIR is a potent inhibitor of GSK3 activity (<xref ref-type="bibr" rid="R107">Wu et al., 2015</xref>), an experimental tool widely used as a potent activator of downstream WNT/β-Catenin signalling. We observed more pronounced effects of CHIR (increasing BRACHYURY expression, <italic>TCF7</italic> and <italic>LEF1</italic>) than recombinant WNT3A protein when human primed cells were treated and CHIR treatment might therefore not always recapitulate a physiological response to WNT signalling. Except for <italic>TCF7L1</italic>, the remaining members of the TCF/LEF family exhibit extensive alternative splicing, which may be undetected by our current antibodies, accounting for differences between mRNA and protein levels. Finally, here we focussed on canonical WNT/β-catenin signalling, future research should include studying functions of non-canonical WNT signalling mechanisms in stem cell models of early human development.</p></sec></sec><sec id="S13" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S14"><title>Human and mouse stem cell lines</title><p id="P30">The HNES1, HNES3 (<xref ref-type="bibr" rid="R27">Guo et al., 2016</xref>), cR-H9 (<xref ref-type="bibr" rid="R26">Guo et al., 2017</xref>) and NIPSC3 (<xref ref-type="bibr" rid="R12">Bredenkamp et al., 2019</xref>) cell lines were a generous gift from Professor Austin Smith (Living Systems Institute, University of Exeter) after granted regulatory approval by the UK Stem Cell Committee. WA07 and WA09 were obtained from WiCell (Madison, Wisconsin). IMR-90 and KOLF2.1J human iPS cell lines were a kind gift from Dr Eunchai Kang (Institute of Medical Sciences, University of Aberdeen). E14Tg2a (<xref ref-type="bibr" rid="R17">Doetschman et al., 1987</xref>), wildtype AinV18 ES cells were a kind gift from Todd Evans (<xref ref-type="bibr" rid="R100">Turbendian et al., 2013</xref>) and the JNST wildtype cell line was derived in-house previously (<xref ref-type="bibr" rid="R49">Kraunsoe et al., 2023</xref>). All cell lines were all expanded in culture conditions that reflect their states of pluripotency and routinely tested for mycoplasma contamination in-house using PCR and tested negative. DNA content analysis was performed to monitor the karyotypic status of all cell lines involved in this study.</p></sec><sec id="S15"><title>Mouse embryonic stem cell culture</title><p id="P31">JNST #32, E14Tg2a and AinV18 (WT) mouse embryonic stem cells were cultured on 0.15% gelatin-coated plates in 2i+LIF to maintain a state of naïve pluripotency, which consisted of N2B27 supplemented with 1 μM PD0325901 (Tocris), 3 μM CHIR99021 (Tocris) and 10 ng/mL mouse recombinant LIF (Cambridge Stem Cell Institute or Peprotech). Cells were routinely cultured and passaged using Accutase (BioLegend) every 2-3 days. Epiblast stem cells (EpiSCs) were cultured to maintain primed pluripotency on 10 μg/mL bovine plasma fibronectin (Sigma Aldrich) coated plates in AFX medium which consisted of N2B27 supplemented with 10 ng/mL human/mouse/rat recombinant ACTIVIN A (Peprotech), 12 ng/mL FGF2 (Cambridge Stem Cell Institute) and 2 μM XAV939 (Tocris). EpiSCs were passaged using Accutase every 2-3 days depending on growth rate and initial seeding density. 10 μM ROCKi (Tocris) was added to N2B27-AFX medium prior at passaging for 24 hours.</p></sec><sec id="S16"><title>Human naïve pluripotent stem cell culture</title><p id="P32">HNES1, HNES3, cR-H9 and NIPSC3 cell lines were routinely maintained on gamma-irradiated DR4 or CF1 mouse embryonic fibroblasts (iMEFs) in N2B27 supplemented with 1 μM <bold>P</bold>D0325901, 2 μM <bold>X</bold>AV939, 2 μM <bold>G</bold>ö6983 and 10 ng/mL human recombinant <bold>L</bold>IF, termed <bold>PXGL</bold> as previously described (<xref ref-type="bibr" rid="R12">Bredenkamp et al., 2019</xref>; <xref ref-type="bibr" rid="R26">Guo et al., 2017</xref>). HNES cells were passaged every 3 to 4 days during exponential growth using Accutase for 12 minutes at 37°C and plated in PXGL with 10 μM Y-27635 for 24 hours. To improve attachment rate, Geltrex was diluted 1:4 with ice DMEM and 30 μL was added per 6-well. Cells used for experiments were cultured for no more than 6 consecutive times.</p><p id="P33">For feeder-free culture, stock Geltrex solution was prediluted 1:4 with ice cold DMEM and gently inverted. For coating plates, 1 mL of ice cold DMEM was added to each 6 well plate with 40 μL of prediluted Geltrex solution. Plates were incubated overnight at 4°C and then 1 hour at 37°C prior to use. Alternatively, 50 μL of diluted Geltrex solution was “spiked” into PXGL+Y at plating.</p></sec><sec id="S17"><title>Capacitation of human naïve ES cells</title><p id="P34">HNES1 and HNES3 cells were capacitated as previously described (<xref ref-type="bibr" rid="R85">Rostovskaya et al., 2019</xref>). Briefly, HNES1 and HNES3 cells were plated at 40,000 cells per 6-well in PXGL+Y for 24 hours. The next day, cells were washed once with DPBS (Gibco) and switched to N2B27 supplemented with 2 μM XAV939 (Tocris) for 10 days. After which, cells were passaged using Accutase (Biolegend) onto diluted Geltrex (1:100) coated plates in AFX or StemFlex (Thermo) medium for at least 3 passages before being used for experimentation.</p></sec><sec id="S18"><title>Primed/conventional human pluripotent stem cell culture</title><p id="P35">pHNES1, pHNES3, H9 embryonic stem cell lines were routinely cultured on Geltrex-coated plates (1:100 dilution overnight at 4°C then 1 hour at 37°C before use) in StemFlex medium. Confluent cells were propagated using Accutase for 5 minutes at 37°C and replated in StemFlex medium supplemented with 10 μM Y-27635 for 24 hours.</p></sec><sec id="S19"><title>Hypoblast differentiation</title><p id="P36">Differentiation of HNES cells towards hypoblast cells was performed as previously described (<xref ref-type="bibr" rid="R15">Dattani et al., 2024</xref>). HNES cells were seeded on Geltrex-coated plates in PXGL with 10 μM ROCKi for 24 hours. The next day, the cells were washed twice with 1x PBS solution and the medium was exchanged to N2B27 supplemented with PDA83 (HNES1; 1.5 μM PD03 and 1.5 μM A8301) (HNES3 and cR-H9; 1 μM PD03 and 1 μM A8301) for 24 hours. The medium was then exchanged to N2B27 supplemented with 50 ng/mL human recombinant FGF4 (Thermo), 1 μM A8301 and 1 μM XAV939 for a further 48 hours until the end of the assay. Note that the HNES1 cell line exhibits greater variability in their inductive ability to form hypoblast at the expense of trophectoderm.</p></sec><sec id="S20"><title>Trophectoderm differentiation</title><p id="P37">HNES cells were induced to differentiate into trophectoderm cells as previously described (<xref ref-type="bibr" rid="R25">Guo et al., 2021</xref>). Naïve ES cells on day 3 or 4 (depending on growth) were passaged onto Geltrex-coated plates in PXGL+Y at a seeding density of 8-10,000 cells per cm<sup>2</sup>. The next day, cells were washed once with PBS and switched to differentiation medium that consisted of N2B27 supplemented with PD0352901 and A8301 at titrated concentrations relevant to each cell line as follows: HNES1 (2 μM PD03 and A8301), HNES3 and cR-H9 (1.5 μM PD03 and A8301). The differentiation medium was refreshed daily and monitored for hallmark signs of differentiation (widespread epithelisation after 24 hours).</p></sec><sec id="S21"><title>nEnd differentiation</title><p id="P38">HNES cells were differentiated into naïve endoderm (nEND) cells as previously described (Linneberg-Agerholm., 2019; <xref ref-type="bibr" rid="R60">Mackinlay et al., 2021</xref>). To reduce cell death under feeder-free conditions (Geltrex-coated plates), the concentration of ACTIVIN A was reduced to 50 ng/mL. HNES cells were seeded on Geltrex-coated plates in PXGL with 10 μM for 24 hours. The next day, the cells were washed twice with 1x PBS exchanged to N2B27 supplemented with 50 ng/mL ACTIVIN A, 3 μM CHIR99021 and 10 ng/mL human LIF for 5-6 days. Medium was refreshed daily until the end of the assay.</p></sec><sec id="S22"><title>Immunostaining of samples</title><p id="P39">Ibidi-treated 8-well chamber slides (Ibidi) were used for immunofluorescence microscopy. Cells were fixed with 4% paraformaldehyde solution for 20 minutes at room temperature (RT) and subsequently washed three times with 1x PBS. Samples that were not processed immediately were stored at 4°C in PBS. Permeabilisation was performed using 0.5% TritonX-100-PBS for 25 minutes at RT and then blocked (5% Donkey Serum (Sigma-Aldrich), 5% BSA (Sigma-Aldrich) with 0.25% Triton-X in PBS) for 1 hour at RT on an orbital shaking platform. Primary antibodies were diluted accordingly in blocking solution and incubated overnight at 4°C. The next day, samples were washed three times with PBST (PBS with 0.02% Tween-20) and incubated with secondary antibodies/DAPI in blocking solution for 2 hours at RT on an orbital shaking platform set at 65 rpm. Samples were washed three times with 1x PBST and finally, changed to PBS prior to imaging.</p></sec><sec id="S23"><title>Confocal microscopy</title><p id="P40">All images were acquired using either a Leica SP5 or LSM-880 confocal microscope with either Leica, Nikon Elements or ZEN Black software, respectively. To minimise crosstalk between the channels, laser intensities were set and not adjusted throughout each imaging session. Imagining emission spectra tracks were reduced to limit bleed through. To normalise or improve the signal-noise ratio for each fluorophore, the digital gain was adjusted accordingly. TCF/LEF expression was normalised to human and mouse primed samples and TCF7/LEF1 was cross-examined with human primed ES cells treated with CHIR for 24 hours. These image settings were saved and used for each experiment and were not altered. Signal to noise reduction was performed to decrease the non-specific binding of the AF488 anti-mouse secondary antibody to unspecified components of Geltrex which was used to coat the Ibidi imaging chambers.</p></sec><sec id="S24"><title>Intracellular flow cytometry</title><p id="P41">Preparation of samples was performed as previously described (<xref ref-type="bibr" rid="R20">Festuccia and Chambers, 2011</xref>) with minor modifications. Cells were dissociated using Accutase and resuspended in ice cold 1% PFA and fixed for 1 hour at 4°C. Samples were washed once with 1x PBS and permeabilised with 70% chilled methanol-PBS solution for 1 hour on ice. Blocking was performed using 5% donkey serum, 5% BSA in PBS for 1 hour at 4°C. Primary antibodies (1:100 dilution) were added directly to blocking buffer and incubated for 1 hour. Samples were washed three times with 1:5 diluted blocking buffer. Secondary antibody staining (1:1000 dilution) was performed for 1 hour at 4°C and were subsequently washed three times. Finally, samples were resuspended into 300 μL of wash buffer and stored at 4°C for analysis (BD Fortessa X-20). Data analysis was carried out using Flow Jo software. For each experiment, a minimum of 20,000 single cells (events) were gated.</p></sec><sec id="S25"><title>RNA extraction, cDNA synthesis and qRT-PCR</title><p id="P42">Samples were lysed in 6-well plates using Lysis buffer and RNA was extracting using a Qiagen RNeasy column prep kit using the manufacturer’s instructions (Qiagen). RNA was eluted into RNA storage solution (Thermo) and was evaluated for integrity and signs of degradation by mixing 5 μL with 5 μL of 2x RNA buffer (Thermo) and electrophoresed for 25 minutes on a 1% agarose gel. Three distinct bands representing ribosomal subunits and tRNAs were always present with no smearing. Samples with smearing or no clear tRNA band were disposed. 500 ng of RNA was routinely reversed transcribed using SuperScript IV (Thermo) as per of the manufacturer’s instructions, however, only 0.5 μL of SSIV RT was used per reaction. cDNA was then diluted 1:10 with nuclease-free water. To ensure complete reverse transcription, 2 μL of diluted cDNA was mixed with DreamTaq 2x Master mix to amplify <italic>GAPDH</italic> and ran on a 1% gel for 30 minutes at 125 V. Only one distinct band was observed of equal intensity.</p><p id="P43">qRT-PCR was performed using Power Up SyBR Green MasterMix (Applied Biosystems) in 384-well white qPCR plates (Applied Biosystems) as technical quadruplicates (5 μL reactions). cT values were measured using the LightCycler II machine. cT values were obtained using the delta delta cT method and the average of <italic>UBC</italic> and <italic>ACTB</italic> were used as internal reference genes for normalisation of relative expression. Expression data were analysed using Prism Graphpad V10 along with statistical analysis. Unless specified, all experiments were performed with at least three independent cell lines (HNES1, HNES3 and cR-H9).</p><p id="P44">Primer pairs were tested to assess the melt curve, binding affinities and off-target amplification. Primers were used in RT-PCR reactions using OneTaq master mix (NEB) and PCR products were electrophoresed on a 1% agarose gel. Primers which generated a single PCR product at the predicted size were used. Several primer pairs were redesigned due to single nucleotide polymorphisms (SNPs) that interrupted annealing of the primers and reduced their efficiency. All primer pairs used here were obtained from previously published resources, the Harvard primer bank or designed using Primer-blast software. Their forward and reverse sequences are shown in table two.</p></sec><sec id="S26"><title>Statistics and reproducibility</title><p id="P45">All statistical analyses were carried out using GraphPad Prism V10. Individual details of statistical methods used for each experiment are presented in each figure legend. Immunofluorescence microscopy experiments were performed in at least three independent cell lines; HNES1, HNES3 (Guo et., 2016) and cR-H9 (<xref ref-type="bibr" rid="R26">Guo et al., 2017</xref>) and images presented were representative of 5 fields of view. qRT-PCR experiments were performed on all three independent cell lines with technical quadruplicates. Flow cytometry experiments were performed on all three independent cell lines and at least 20,000 events were recorded. In our hands, we observed comparatively lower levels of hypoblast cells and more efficient trophectoderm differentiation in the HNES1 cell line.</p><p id="P46">Antibodies denoted * in <xref ref-type="supplementary-material" rid="SD1">table S1</xref> (TCF7, TCF7L1, TCF7L2 and LEF1) from Santa Cruz exhibited varying levels of activity and were difficult reproduce initial observations. Therefore, care should be taken when using these antibodies.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Suppl Figures</label><media xlink:href="EMS199386-supplement-Suppl_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d41aAcEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplementary Table</label><media xlink:href="EMS199386-supplement-Supplementary_Table.pdf" mimetype="application" mime-subtype="pdf" id="d41aAcEcB" position="anchor"/></supplementary-material></sec></body><back><ack id="S27"><title>Acknowledgements</title><p>We would like to thank all members of the Hoppler and Nichols groups for critical feedback and helpful discussions on this project and Yvonne Turnbull for lab management. We thank Dr Debbie Wilkinson (Aberdeen Advanced Microscopy and Histology), Ann Wheeler (Edinburgh Imaging) and Darran Clements (Cambridge imaging) for their assistance with confocal and widefield microscopy. We thank Dr Andrea Holme (Ian Fraser Cytometry Centre, University of Aberdeen) for her kind assistance with flow cytometry.</p><sec id="S28"><title>Funding Acquisition</title><p>This study was supported from BBSRC project grants BB/S018190/1 and BB/Y001974/1.</p></sec></ack><fn-group><fn fn-type="con" id="FN1"><p id="P47"><bold>Author Contributions</bold></p><p id="P48">CR and SH conceptualised this study with input from JN and TA. CR and TA performed experiments. MS designed and validated the TCF/LEF primers used for qPCR and RG provided tissue culture assistance. CR carried out all analysis and generated figures. CR and SH wrote the manuscript with input from TA, MS, RG and JN. All authors reviewed the final manuscript prior to submission.</p></fn><fn fn-type="conflict" id="FN2"><p id="P49"><bold>Declaration of Interests</bold></p><p id="P50">The authors disclose no financial or competing interests.</p></fn></fn-group><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosi</surname><given-names>G</given-names></name><name><surname>Voloshanenko</surname><given-names>O</given-names></name><name><surname>Eckert</surname><given-names>AF</given-names></name><name><surname>Kranz</surname><given-names>D</given-names></name><name><surname>Nienhaus</surname><given-names>GU</given-names></name><name><surname>Boutros</surname><given-names>M</given-names></name></person-group><article-title>Allele-specific endogenous tagging and quantitative analysis of beta-catenin in colorectal cancer cells</article-title><source>Elife</source><year>2022</year><volume>11</volume><pub-id pub-id-type="pmcid">PMC8752093</pub-id><pub-id pub-id-type="pmid">35014953</pub-id><pub-id pub-id-type="doi">10.7554/eLife.64498</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amita</surname><given-names>M</given-names></name><name><surname>Adachi</surname><given-names>K</given-names></name><name><surname>Alexenko</surname><given-names>AP</given-names></name><name><surname>Sinha</surname><given-names>S</given-names></name><name><surname>Schust</surname><given-names>DJ</given-names></name><name><surname>Schulz</surname><given-names>LC</given-names></name><name><surname>Roberts</surname><given-names>RM</given-names></name><name><surname>Ezashi</surname><given-names>T</given-names></name></person-group><article-title>Complete and unidirectional conversion of human embryonic stem cells to trophoblast by BMP4</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2013</year><pub-id pub-id-type="pmcid">PMC3612666</pub-id><pub-id pub-id-type="pmid">23493551</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1303094110</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Athanasouli</surname><given-names>P</given-names></name><name><surname>Balli</surname><given-names>M</given-names></name><name><surname>De Jaime-Soguero</surname><given-names>A</given-names></name><name><surname>Boel</surname><given-names>A</given-names></name><name><surname>Papanikolaou</surname><given-names>S</given-names></name><name><surname>van der Veer</surname><given-names>BK</given-names></name><name><surname>Janiszewski</surname><given-names>A</given-names></name><name><surname>Vanhessche</surname><given-names>T</given-names></name><name><surname>Francis</surname><given-names>A</given-names></name><name><surname>El Laithy</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The Wnt/TCF7L1 transcriptional repressor axis drives primitive endoderm formation by antagonizing naive and formative pluripotency</article-title><source>Nat Commun</source><year>2023</year><volume>14</volume><elocation-id>1210</elocation-id><pub-id pub-id-type="pmcid">PMC9984534</pub-id><pub-id pub-id-type="pmid">36869101</pub-id><pub-id pub-id-type="doi">10.1038/s41467-023-36914-1</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardot</surname><given-names>ES</given-names></name><name><surname>Hadjantonakis</surname><given-names>AK</given-names></name></person-group><article-title>Mouse gastrulation: Coordination of tissue patterning, specification and diversification of cell fate</article-title><source>Mech Dev</source><year>2020</year><volume>163</volume><elocation-id>103617</elocation-id><pub-id pub-id-type="pmcid">PMC7534585</pub-id><pub-id pub-id-type="pmid">32473204</pub-id><pub-id pub-id-type="doi">10.1016/j.mod.2020.103617</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrow</surname><given-names>JR</given-names></name><name><surname>Howell</surname><given-names>WD</given-names></name><name><surname>Rule</surname><given-names>M</given-names></name><name><surname>Hayashi</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>KR</given-names></name><name><surname>Capecchi</surname><given-names>MR</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name></person-group><article-title>Wnt3 signaling in the epiblast is required for proper orientation of the anteroposterior axis</article-title><source>Developmental Biology</source><year>2007</year><pub-id pub-id-type="pmid">18028899</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayerl</surname><given-names>J</given-names></name><name><surname>Ayyash</surname><given-names>M</given-names></name><name><surname>Shani</surname><given-names>T</given-names></name><name><surname>Manor</surname><given-names>YS</given-names></name><name><surname>Gafni</surname><given-names>O</given-names></name><name><surname>Massarwa</surname><given-names>R</given-names></name><name><surname>Kalma</surname><given-names>Y</given-names></name><name><surname>Aguilera-Castrejon</surname><given-names>A</given-names></name><name><surname>Zerbib</surname><given-names>M</given-names></name><name><surname>Amir</surname><given-names>H</given-names></name><etal/></person-group><article-title>Principles of signaling pathway modulation for enhancing human naive pluripotency induction</article-title><source>Cell Stem Cell</source><year>2021</year><pub-id pub-id-type="pmcid">PMC8423434</pub-id><pub-id pub-id-type="pmid">33915080</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2021.04.001</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergmann</surname><given-names>S</given-names></name><name><surname>Penfold</surname><given-names>CA</given-names></name><name><surname>Slatery</surname><given-names>E</given-names></name><name><surname>Siriwardena</surname><given-names>D</given-names></name><name><surname>Drummer</surname><given-names>C</given-names></name><name><surname>Clark</surname><given-names>S</given-names></name><name><surname>Strawbridge</surname><given-names>SE</given-names></name><name><surname>Kishimoto</surname><given-names>K</given-names></name><name><surname>Vickers</surname><given-names>A</given-names></name><name><surname>Tewary</surname><given-names>M</given-names></name><etal/></person-group><article-title>Spatial profiling of early primate gastrulation in utero</article-title><source>Nature</source><year>2022</year><volume>609</volume><fpage>136</fpage><lpage>143</lpage><pub-id pub-id-type="pmcid">PMC7614364</pub-id><pub-id pub-id-type="pmid">35709828</pub-id><pub-id pub-id-type="doi">10.1038/s41586-022-04953-1</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biechele</surname><given-names>S</given-names></name><name><surname>Cockburn</surname><given-names>K</given-names></name><name><surname>Lanner</surname><given-names>F</given-names></name><name><surname>Cox</surname><given-names>BJ</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name></person-group><article-title>Porcn-dependent Wnt signaling is not required prior to mouse gastrulation</article-title><source>Development (Cambridge)</source><year>2013</year><pub-id pub-id-type="pmid">23760955</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blakeley</surname><given-names>P</given-names></name><name><surname>Fogarty</surname><given-names>NME</given-names></name><name><surname>Del Valle</surname><given-names>I</given-names></name><name><surname>Wamaitha</surname><given-names>SE</given-names></name><name><surname>Hu</surname><given-names>TX</given-names></name><name><surname>Elder</surname><given-names>K</given-names></name><name><surname>Snell</surname><given-names>P</given-names></name><name><surname>Christie</surname><given-names>L</given-names></name><name><surname>Robson</surname><given-names>P</given-names></name><name><surname>Niakan</surname><given-names>KK</given-names></name></person-group><article-title>Defining the three cell lineages of the human blastocyst by single-cell RNA-seq</article-title><source>Development (Cambridge)</source><year>2015</year><pub-id pub-id-type="pmcid">PMC4631772</pub-id><pub-id pub-id-type="pmid">26487783</pub-id><pub-id pub-id-type="doi">10.1242/dev.131235</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boroviak</surname><given-names>T</given-names></name><name><surname>Loos</surname><given-names>R</given-names></name><name><surname>Bertone</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Nichols</surname><given-names>J</given-names></name></person-group><article-title>The ability of inner-cell-mass cells to self-renew as embryonic stem cells is acquired following epiblast specification</article-title><source>Nature Cell Biology</source><year>2014</year><pub-id pub-id-type="pmcid">PMC4878656</pub-id><pub-id pub-id-type="pmid">24859004</pub-id><pub-id pub-id-type="doi">10.1038/ncb2965</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boroviak</surname><given-names>T</given-names></name><name><surname>Nichols</surname><given-names>J</given-names></name></person-group><article-title>Primate embryogenesis predicts the hallmarks of human naïve pluripotency</article-title><source>Development</source><year>2017</year><fpage>175</fpage><lpage>186</lpage><pub-id pub-id-type="pmcid">PMC5430762</pub-id><pub-id pub-id-type="pmid">28096211</pub-id><pub-id pub-id-type="doi">10.1242/dev.145177</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bredenkamp</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>J</given-names></name><name><surname>Stirparo</surname><given-names>GG</given-names></name><name><surname>von Meyenn</surname><given-names>F</given-names></name><name><surname>Dietmann</surname><given-names>S</given-names></name><name><surname>Baker</surname><given-names>D</given-names></name><name><surname>Drummond</surname><given-names>R</given-names></name><name><surname>Ren</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><etal/></person-group><article-title>Wnt Inhibition Facilitates RNA-Mediated Reprogramming of Human Somatic Cells to Naive Pluripotency</article-title><source>Stem Cell Reports</source><year>2019</year><volume>13</volume><fpage>1083</fpage><lpage>1098</lpage><pub-id pub-id-type="pmcid">PMC6915845</pub-id><pub-id pub-id-type="pmid">31708477</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2019.10.009</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadigan</surname><given-names>KM</given-names></name><name><surname>Waterman</surname><given-names>ML</given-names></name></person-group><article-title>TCF/LEFs and Wnt signaling in the nucleus</article-title><source>Cold Spring Harb Perspect Biol</source><year>2012</year><volume>4</volume><pub-id pub-id-type="pmcid">PMC3536346</pub-id><pub-id pub-id-type="pmid">23024173</pub-id><pub-id pub-id-type="doi">10.1101/cshperspect.a007906</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Blair</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name></person-group><article-title>Robust self-renewal of rat embryonic stem cells requires fine-tuning of glycogen synthase kinase-3 inhibition</article-title><source>Stem Cell Reports</source><year>2013</year><volume>1</volume><fpage>209</fpage><lpage>217</lpage><pub-id pub-id-type="pmcid">PMC3849254</pub-id><pub-id pub-id-type="pmid">24319657</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2013.07.003</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dattani</surname><given-names>A</given-names></name><name><surname>Corujo-Simon</surname><given-names>E</given-names></name><name><surname>Radley</surname><given-names>A</given-names></name><name><surname>Heydari</surname><given-names>T</given-names></name><name><surname>Taheriabkenar</surname><given-names>Y</given-names></name><name><surname>Carlisle</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Liddle</surname><given-names>C</given-names></name><name><surname>Mill</surname><given-names>J</given-names></name><name><surname>Zandstra</surname><given-names>PW</given-names></name><etal/></person-group><article-title>Naive pluripotent stem cell-based models capture FGF-dependent human hypoblast lineage specification</article-title><source>Cell Stem Cell</source><year>2024</year><volume>31</volume><fpage>1058</fpage><lpage>1071</lpage><elocation-id>e1055</elocation-id><pub-id pub-id-type="pmid">38823388</pub-id></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dattani</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Liddle</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Guo</surname><given-names>G</given-names></name></person-group><article-title>Suppression of YAP safeguards human naive pluripotency</article-title><source>Development</source><year>2022</year><volume>149</volume><pub-id pub-id-type="pmcid">PMC9845734</pub-id><pub-id pub-id-type="pmid">36398796</pub-id><pub-id pub-id-type="doi">10.1242/dev.200988</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doetschman</surname><given-names>T</given-names></name><name><surname>Gregg</surname><given-names>RG</given-names></name><name><surname>Maeda</surname><given-names>N</given-names></name><name><surname>Hooper</surname><given-names>ML</given-names></name><name><surname>Melton</surname><given-names>DW</given-names></name><name><surname>Thompson</surname><given-names>S</given-names></name><name><surname>Smithies</surname><given-names>O</given-names></name></person-group><article-title>Targetted correction of a mutant HPRT gene in mouse embryonic stem cells</article-title><source>Nature</source><year>1987</year><volume>330</volume><fpage>576</fpage><lpage>578</lpage><pub-id pub-id-type="pmid">3683574</pub-id></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dziedzicka</surname><given-names>D</given-names></name><name><surname>Tewary</surname><given-names>M</given-names></name><name><surname>Keller</surname><given-names>A</given-names></name><name><surname>Tilleman</surname><given-names>L</given-names></name><name><surname>Prochazka</surname><given-names>L</given-names></name><name><surname>Ostblom</surname><given-names>J</given-names></name><name><surname>De Deckersberg</surname><given-names>Couvreu</given-names></name><name><surname>Markouli</surname><given-names>C</given-names></name><name><surname>Franck</surname><given-names>S</given-names></name><name><surname>Van Nieuwerburgh</surname><given-names>F</given-names></name><etal/></person-group><article-title>Endogenous suppression of WNT signalling in human embryonic stem cells leads to low differentiation propensity towards definitive endoderm</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><elocation-id>6137</elocation-id><pub-id pub-id-type="pmcid">PMC7969605</pub-id><pub-id pub-id-type="pmid">33731744</pub-id><pub-id pub-id-type="doi">10.1038/s41598-021-85447-4</pub-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>MJ</given-names></name><name><surname>Kaufman</surname><given-names>MH</given-names></name></person-group><article-title>Establishment in culture of pluripotential cells from mouse embryos</article-title><source>Nature</source><year>1981</year><volume>292</volume><fpage>154</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">7242681</pub-id></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Festuccia</surname><given-names>N</given-names></name><name><surname>Chambers</surname><given-names>I</given-names></name></person-group><article-title>Quantification of pluripotency transcription factor levels in embryonic stem cells by flow cytometry</article-title><source>Current Protocols in Stem Cell Biology</source><year>2011</year><pub-id pub-id-type="pmid">22135081</pub-id></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funa</surname><given-names>NS</given-names></name><name><surname>Schachter</surname><given-names>KA</given-names></name><name><surname>Lerdrup</surname><given-names>M</given-names></name><name><surname>Ekberg</surname><given-names>J</given-names></name><name><surname>Hess</surname><given-names>K</given-names></name><name><surname>Dietrich</surname><given-names>N</given-names></name><name><surname>Honoré</surname><given-names>C</given-names></name><name><surname>Hansen</surname><given-names>K</given-names></name><name><surname>Semb</surname><given-names>H</given-names></name></person-group><article-title>β-Catenin Regulates Primitive Streak Induction through Collaborative Interactions with SMAD2/SMAD3 and OCT4</article-title><source>Cell Stem Cell</source><year>2015</year><pub-id pub-id-type="pmid">25921273</pub-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gafni</surname><given-names>O</given-names></name><name><surname>Weinberger</surname><given-names>L</given-names></name><name><surname>Mansour</surname><given-names>AA</given-names></name><name><surname>Manor</surname><given-names>YS</given-names></name><name><surname>Chomsky</surname><given-names>E</given-names></name><name><surname>Ben-Yosef</surname><given-names>D</given-names></name><name><surname>Kalma</surname><given-names>Y</given-names></name><name><surname>Viukov</surname><given-names>S</given-names></name><name><surname>Maza</surname><given-names>I</given-names></name><name><surname>Zviran</surname><given-names>A</given-names></name><etal/></person-group><article-title>Derivation of novel human ground state naive pluripotent stem cells</article-title><source>Nature</source><year>2013</year><pub-id pub-id-type="pmid">24172903</pub-id></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galceran</surname><given-names>J</given-names></name><name><surname>Farinas</surname><given-names>I</given-names></name><name><surname>Depew</surname><given-names>MJ</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Grosschedl</surname><given-names>R</given-names></name></person-group><article-title>Wnt3a-/--like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice</article-title><source>Genes Dev</source><year>1999</year><volume>13</volume><fpage>709</fpage><lpage>717</lpage><pub-id pub-id-type="pmcid">PMC316557</pub-id><pub-id pub-id-type="pmid">10090727</pub-id><pub-id pub-id-type="doi">10.1101/gad.13.6.709</pub-id></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galceran</surname><given-names>J</given-names></name><name><surname>Hsu</surname><given-names>SC</given-names></name><name><surname>Grosschedl</surname><given-names>R</given-names></name></person-group><article-title>Rescue of a Wnt mutation by an activated form of LEF-1: Regulation of maintenance but not initiation of Brachyury expression</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2001</year><pub-id pub-id-type="pmcid">PMC37493</pub-id><pub-id pub-id-type="pmid">11447280</pub-id><pub-id pub-id-type="doi">10.1073/pnas.151258098</pub-id></element-citation></ref><ref id="R25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>G</given-names></name><name><surname>Stirparo</surname><given-names>GG</given-names></name><name><surname>Strawbridge</surname><given-names>SE</given-names></name><name><surname>Spindlow</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>J</given-names></name><name><surname>Dattani</surname><given-names>A</given-names></name><name><surname>Yanagida</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>MA</given-names></name><name><surname>Myers</surname><given-names>S</given-names></name><etal/></person-group><article-title>Human naive epiblast cells possess unrestricted lineage potential</article-title><source>Cell Stem Cell</source><year>2021</year><volume>28</volume><fpage>1040</fpage><lpage>1056</lpage><elocation-id>e1046</elocation-id><pub-id pub-id-type="pmcid">PMC8189439</pub-id><pub-id pub-id-type="pmid">33831366</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2021.02.025</pub-id></element-citation></ref><ref id="R26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>G</given-names></name><name><surname>von Meyenn</surname><given-names>F</given-names></name><name><surname>Rostovskaya</surname><given-names>M</given-names></name><name><surname>Clarke</surname><given-names>J</given-names></name><name><surname>Dietmann</surname><given-names>S</given-names></name><name><surname>Baker</surname><given-names>D</given-names></name><name><surname>Sahakyan</surname><given-names>A</given-names></name><name><surname>Myers</surname><given-names>S</given-names></name><name><surname>Bertone</surname><given-names>P</given-names></name><name><surname>Reik</surname><given-names>W</given-names></name><etal/></person-group><article-title>Epigenetic resetting of human pluripotency</article-title><source>Development</source><year>2017</year><volume>144</volume><fpage>2748</fpage><lpage>2763</lpage><pub-id pub-id-type="pmcid">PMC5560041</pub-id><pub-id pub-id-type="pmid">28765214</pub-id><pub-id pub-id-type="doi">10.1242/dev.146811</pub-id></element-citation></ref><ref id="R27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>G</given-names></name><name><surname>von Meyenn</surname><given-names>F</given-names></name><name><surname>Santos</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Reik</surname><given-names>W</given-names></name><name><surname>Bertone</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Nichols</surname><given-names>J</given-names></name></person-group><article-title>Naive Pluripotent Stem Cells Derived Directly from Isolated Cells of the Human Inner Cell Mass</article-title><source>Stem Cell Reports</source><year>2016</year><volume>6</volume><fpage>437</fpage><lpage>446</lpage><pub-id pub-id-type="pmcid">PMC4834040</pub-id><pub-id pub-id-type="pmid">26947977</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2016.02.005</pub-id></element-citation></ref><ref id="R28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanna</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>AW</given-names></name><name><surname>Saha</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Lengner</surname><given-names>CJ</given-names></name><name><surname>Soldner</surname><given-names>F</given-names></name><name><surname>Cassady</surname><given-names>JP</given-names></name><name><surname>Muffat</surname><given-names>J</given-names></name><name><surname>Carey</surname><given-names>BW</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name></person-group><article-title>Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2010</year><pub-id pub-id-type="pmcid">PMC2889088</pub-id><pub-id pub-id-type="pmid">20442331</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1004584107</pub-id></element-citation></ref><ref id="R29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>JA</given-names></name><name><surname>Wu</surname><given-names>CI</given-names></name><name><surname>Merrill</surname><given-names>BJ</given-names></name></person-group><article-title>Tcf7l1 prepares epiblast cells in the gastrulating mouse embryo for lineage specification</article-title><source>Development (Cambridge)</source><year>2013</year><pub-id pub-id-type="pmcid">PMC3621485</pub-id><pub-id pub-id-type="pmid">23487311</pub-id><pub-id pub-id-type="doi">10.1242/dev.087387</pub-id></element-citation></ref><ref id="R30"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hoppler</surname><given-names>S</given-names></name><name><surname>Moon</surname><given-names>RT</given-names></name></person-group><source>Wnt signaling in development and disease : molecular mechanisms and biological functions</source><publisher-name>Wiley Blackwell</publisher-name><publisher-loc>Hoboken, New Jersey</publisher-loc><year>2014</year><fpage>1</fpage><comment>online resource</comment></element-citation></ref><ref id="R31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoppler</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name></person-group><article-title>Cell-to-Cell Signalling in Development: Wnt Signalling</article-title><source>eLS</source><year>2014</year></element-citation></ref><ref id="R32"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hoppler</surname><given-names>S</given-names></name><name><surname>Waterman</surname><given-names>ML</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Hoppler</surname><given-names>S</given-names></name><name><surname>Moon</surname><given-names>RT</given-names></name></person-group><chapter-title>Evolutionary Diversification of vertebrate TCF/LEF structure, function, and regulation</chapter-title><source>Wnt Signaling in Development and Disease: Molecular Mechanisms and Biological Functions</source><publisher-name>John Wiley &amp; Sons, Ltd</publisher-name><publisher-loc>Hoboken, NJ</publisher-loc><year>2014</year><fpage>225</fpage><lpage>237</lpage></element-citation></ref><ref id="R33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>SMA</given-names></name><name><surname>Mishina</surname><given-names>YM</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Cheung</surname><given-names>A</given-names></name><name><surname>Stegmeier</surname><given-names>F</given-names></name><name><surname>Michaud</surname><given-names>GA</given-names></name><name><surname>Charlat</surname><given-names>O</given-names></name><name><surname>Wiellette</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wiessner</surname><given-names>S</given-names></name><etal/></person-group><article-title>Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</article-title><source>Nature</source><year>2009</year><pub-id pub-id-type="pmid">19759537</pub-id></element-citation></ref><ref id="R34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Io</surname><given-names>S</given-names></name><name><surname>Kabata</surname><given-names>M</given-names></name><name><surname>Iemura</surname><given-names>Y</given-names></name><name><surname>Semi</surname><given-names>K</given-names></name><name><surname>Morone</surname><given-names>N</given-names></name><name><surname>Minagawa</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Okamoto</surname><given-names>I</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Kojima</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Capturing human trophoblast development with naive pluripotent stem cells in vitro</article-title><source>Cell Stem Cell</source><year>2021</year><pub-id pub-id-type="pmid">33831365</pub-id></element-citation></ref><ref id="R35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwatsuki</surname><given-names>K</given-names></name><name><surname>Oikawa</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>H</given-names></name><name><surname>Penfold</surname><given-names>CA</given-names></name><name><surname>Sanbo</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Hochi</surname><given-names>S</given-names></name><name><surname>Kurimoto</surname><given-names>K</given-names></name><name><surname>Hirabayashi</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name></person-group><article-title>Rat post-implantation epiblast-derived pluripotent stem cells produce functional germ cells</article-title><source>Cell Rep Methods</source><year>2023</year><volume>3</volume><elocation-id>100542</elocation-id><pub-id pub-id-type="pmcid">PMC10475792</pub-id><pub-id pub-id-type="pmid">37671016</pub-id><pub-id pub-id-type="doi">10.1016/j.crmeth.2023.100542</pub-id></element-citation></ref><ref id="R36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>M</given-names></name><name><surname>Fidanza</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>AH</given-names></name><name><surname>Rybtsov</surname><given-names>S</given-names></name><name><surname>Axton</surname><given-names>R</given-names></name><name><surname>Kydonaki</surname><given-names>M</given-names></name><name><surname>Meek</surname><given-names>S</given-names></name><name><surname>Burdon</surname><given-names>T</given-names></name><name><surname>Medvinsky</surname><given-names>A</given-names></name><name><surname>Forrester</surname><given-names>LM</given-names></name></person-group><article-title>Modulation of APLNR Signaling Is Required during the Development and Maintenance of the Hematopoietic System</article-title><source>Stem Cell Reports</source><year>2021</year><volume>16</volume><fpage>727</fpage><lpage>740</lpage><pub-id pub-id-type="pmcid">PMC8072025</pub-id><pub-id pub-id-type="pmid">33667414</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2021.02.003</pub-id></element-citation></ref><ref id="R37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>D</given-names></name><name><surname>Levine</surname><given-names>AJ</given-names></name><name><surname>Besser</surname><given-names>D</given-names></name><name><surname>Hemmati-Brivanlou</surname><given-names>A</given-names></name></person-group><article-title>TGFβ/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells</article-title><source>Development</source><year>2005</year><pub-id pub-id-type="pmid">15703277</pub-id></element-citation></ref><ref id="R38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jho</surname><given-names>E-h</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Domon</surname><given-names>C</given-names></name><name><surname>Joo</surname><given-names>C-K</given-names></name><name><surname>Freund</surname><given-names>J-N</given-names></name><name><surname>Costantini</surname><given-names>F</given-names></name></person-group><article-title>Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway</article-title><source>Molecular and Cellular Biology</source><year>2002</year><pub-id pub-id-type="pmcid">PMC134648</pub-id><pub-id pub-id-type="pmid">11809808</pub-id><pub-id pub-id-type="doi">10.1128/MCB.22.4.1172-1183.2002</pub-id></element-citation></ref><ref id="R39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kafri</surname><given-names>P</given-names></name><name><surname>Hasenson</surname><given-names>SE</given-names></name><name><surname>Kanter</surname><given-names>I</given-names></name><name><surname>Sheinberger</surname><given-names>J</given-names></name><name><surname>Kinor</surname><given-names>N</given-names></name><name><surname>Yunger</surname><given-names>S</given-names></name><name><surname>Shav-Tal</surname><given-names>Y</given-names></name></person-group><article-title>Quantifying β-catenin subcellular dynamics and cyclin D1 mRNA transcription during Wnt signaling in single living cells</article-title><source>eLife</source><year>2016</year><pub-id pub-id-type="pmcid">PMC5161448</pub-id><pub-id pub-id-type="pmid">27879202</pub-id><pub-id pub-id-type="doi">10.7554/eLife.16748</pub-id></element-citation></ref><ref id="R40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kajihara</surname><given-names>R</given-names></name><name><surname>Ezaki</surname><given-names>R</given-names></name><name><surname>Ichikawa</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Terada</surname><given-names>T</given-names></name><name><surname>Matsuzaki</surname><given-names>M</given-names></name><name><surname>Horiuchi</surname><given-names>H</given-names></name></person-group><article-title>Wnt signaling blockade is essential for maintaining the pluripotency of chicken embryonic stem cells</article-title><source>Poult Sci</source><year>2024</year><volume>103</volume><elocation-id>103361</elocation-id><pub-id pub-id-type="pmcid">PMC10788285</pub-id><pub-id pub-id-type="pmid">38154448</pub-id><pub-id pub-id-type="doi">10.1016/j.psj.2023.103361</pub-id></element-citation></ref><ref id="R41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>KF</given-names></name><name><surname>Ng</surname><given-names>DY</given-names></name><name><surname>Jayakumaran</surname><given-names>G</given-names></name><name><surname>Wood</surname><given-names>GA</given-names></name><name><surname>Koide</surname><given-names>H</given-names></name><name><surname>Doble</surname><given-names>BW</given-names></name></person-group><article-title>β-catenin enhances Oct-4 activity and reinforces pluripotency through a TCF-independent mechanism</article-title><source>Cell Stem Cell</source><year>2011</year><pub-id pub-id-type="pmcid">PMC3465368</pub-id><pub-id pub-id-type="pmid">21295277</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2010.12.010</pub-id></element-citation></ref><ref id="R42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>SA</given-names></name><name><surname>Park</surname><given-names>Km</given-names></name><name><surname>Fischer</surname><given-names>LA</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Lungjangwa</surname><given-names>T</given-names></name><name><surname>Jimenez</surname><given-names>M</given-names></name><name><surname>Casalena</surname><given-names>D</given-names></name><name><surname>Chew</surname><given-names>B</given-names></name><name><surname>Dietmann</surname><given-names>S</given-names></name><name><surname>Auld</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Probing the signaling requirements for naive human pluripotency by high-throughput chemical screening</article-title><source>Cell Reports</source><year>2021</year><pub-id pub-id-type="pmcid">PMC8272458</pub-id><pub-id pub-id-type="pmid">34133938</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109233</pub-id></element-citation></ref><ref id="R43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Oda</surname><given-names>T</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Artinger</surname><given-names>KB</given-names></name><name><surname>Chandrasekharappa</surname><given-names>SC</given-names></name><name><surname>Driever</surname><given-names>W</given-names></name><name><surname>Chitnis</surname><given-names>AB</given-names></name></person-group><article-title>Repressor activity of Headless/Tcf3 is essential for vertebrate head formation</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>913</fpage><lpage>916</lpage><pub-id pub-id-type="pmcid">PMC4018833</pub-id><pub-id pub-id-type="pmid">11057671</pub-id><pub-id pub-id-type="doi">10.1038/35038097</pub-id></element-citation></ref><ref id="R44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinoshita</surname><given-names>M</given-names></name><name><surname>Barber</surname><given-names>M</given-names></name><name><surname>Mansfield</surname><given-names>W</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Spindlow</surname><given-names>D</given-names></name><name><surname>Stirparo</surname><given-names>GG</given-names></name><name><surname>Dietmann</surname><given-names>S</given-names></name><name><surname>Nichols</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name></person-group><article-title>Capture of Mouse and Human Stem Cells with Features of Formative Pluripotency</article-title><source>Cell Stem Cell</source><year>2021a</year><pub-id pub-id-type="pmcid">PMC8657791</pub-id><pub-id pub-id-type="pmid">34861148</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2021.11.002</pub-id></element-citation></ref><ref id="R45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinoshita</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Planells</surname><given-names>B</given-names></name><name><surname>Klisch</surname><given-names>D</given-names></name><name><surname>Spindlow</surname><given-names>D</given-names></name><name><surname>Masaki</surname><given-names>H</given-names></name><name><surname>Bornelöv</surname><given-names>S</given-names></name><name><surname>Stirparo</surname><given-names>GG</given-names></name><name><surname>Matsunari</surname><given-names>H</given-names></name><name><surname>Uchikura</surname><given-names>A</given-names></name><etal/></person-group><article-title>Pluripotent stem cells related to embryonic disc exhibit common self-renewal requirements in diverse livestock species</article-title><source>Development (Cambridge, England)</source><year>2021b</year><pub-id pub-id-type="pmcid">PMC8714072</pub-id><pub-id pub-id-type="pmid">34874452</pub-id><pub-id pub-id-type="doi">10.1242/dev.199901</pub-id></element-citation></ref><ref id="R46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Castillo-Venzor</surname><given-names>A</given-names></name><name><surname>Penfold</surname><given-names>CA</given-names></name><name><surname>Morgan</surname><given-names>M</given-names></name><name><surname>Mizuno</surname><given-names>N</given-names></name><name><surname>Tang</surname><given-names>WWC</given-names></name><name><surname>Osada</surname><given-names>Y</given-names></name><name><surname>Hirao</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>F</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><etal/></person-group><article-title>Tracing the emergence of primordial germ cells from bilaminar disc rabbit embryos and pluripotent stem cells</article-title><source>Cell Rep</source><year>2021</year><volume>37</volume><elocation-id>109812</elocation-id><pub-id pub-id-type="pmid">34644585</pub-id></element-citation></ref><ref id="R47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohler</surname><given-names>TN</given-names></name><name><surname>De Jonghe</surname><given-names>J</given-names></name><name><surname>Ellermann</surname><given-names>AL</given-names></name><name><surname>Yanagida</surname><given-names>A</given-names></name><name><surname>Herger</surname><given-names>M</given-names></name><name><surname>Slatery</surname><given-names>EM</given-names></name><name><surname>Weberling</surname><given-names>A</given-names></name><name><surname>Munger</surname><given-names>C</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Mulas</surname><given-names>C</given-names></name><etal/></person-group><article-title>Plakoglobin is a mechanoresponsive regulator of naive pluripotency</article-title><source>Nat Commun</source><year>2023</year><volume>14</volume><elocation-id>4022</elocation-id><pub-id pub-id-type="pmcid">PMC10329048</pub-id><pub-id pub-id-type="pmid">37419903</pub-id><pub-id pub-id-type="doi">10.1038/s41467-023-39515-0</pub-id></element-citation></ref><ref id="R48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojima</surname><given-names>Y</given-names></name><name><surname>Kaufman-Francis</surname><given-names>K</given-names></name><name><surname>Studdert</surname><given-names>JB</given-names></name><name><surname>Steiner</surname><given-names>KA</given-names></name><name><surname>Power</surname><given-names>MD</given-names></name><name><surname>Loebel</surname><given-names>DAF</given-names></name><name><surname>Jones</surname><given-names>V</given-names></name><name><surname>Hor</surname><given-names>A</given-names></name><name><surname>De Alencastro</surname><given-names>G</given-names></name><name><surname>Logan</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>The transcriptional and functional properties of mouse epiblast stem cells resemble the anterior primitive streak</article-title><source>Cell Stem Cell</source><year>2014</year><pub-id pub-id-type="pmid">24139757</pub-id></element-citation></ref><ref id="R49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraunsoe</surname><given-names>S</given-names></name><name><surname>Azami</surname><given-names>T</given-names></name><name><surname>Pei</surname><given-names>Y</given-names></name><name><surname>Martello</surname><given-names>G</given-names></name><name><surname>Jones</surname><given-names>K</given-names></name><name><surname>Boroviak</surname><given-names>T</given-names></name><name><surname>Nichols</surname><given-names>J</given-names></name></person-group><article-title>Requirement for STAT3 and its target, TFCP2L1, in self-renewal of naive pluripotent stem cells in vivo and in vitro</article-title><source>Biol Open</source><year>2023</year><volume>12</volume><pub-id pub-id-type="pmcid">PMC9884119</pub-id><pub-id pub-id-type="pmid">36504370</pub-id><pub-id pub-id-type="doi">10.1242/bio.059650</pub-id></element-citation></ref><ref id="R50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>YY</given-names></name><name><surname>Chan</surname><given-names>CH</given-names></name><name><surname>Geng</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>N</given-names></name><name><surname>Keung</surname><given-names>W</given-names></name><name><surname>Cheung</surname><given-names>YF</given-names></name></person-group><article-title>APLNR marks a cardiac progenitor derived with human induced pluripotent stem cells</article-title><source>Heliyon</source><year>2023</year><volume>9</volume><elocation-id>e18243</elocation-id><pub-id pub-id-type="pmcid">PMC10395470</pub-id><pub-id pub-id-type="pmid">37539315</pub-id><pub-id pub-id-type="doi">10.1016/j.heliyon.2023.e18243</pub-id></element-citation></ref><ref id="R51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>TW</given-names></name><name><surname>Ting</surname><given-names>JH</given-names></name><name><surname>Yokoyama</surname><given-names>NN</given-names></name><name><surname>Bernstein</surname><given-names>A</given-names></name><name><surname>van de Wetering</surname><given-names>M</given-names></name><name><surname>Waterman</surname><given-names>ML</given-names></name></person-group><article-title>Wnt activation and alternative promoter repression of LEF1 in colon cancer</article-title><source>Mol Cell Biol</source><year>2006</year><volume>26</volume><fpage>5284</fpage><lpage>5299</lpage><pub-id pub-id-type="pmcid">PMC1592719</pub-id><pub-id pub-id-type="pmid">16809766</pub-id><pub-id pub-id-type="doi">10.1128/MCB.00105-06</pub-id></element-citation></ref><ref id="R52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linneberg-Agerholm</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>YF</given-names></name><name><surname>Romero Herrera</surname><given-names>JA</given-names></name><name><surname>Monteiro</surname><given-names>RS</given-names></name><name><surname>Anderson</surname><given-names>KGV</given-names></name><name><surname>Brickman</surname><given-names>JM</given-names></name></person-group><article-title>Naive human pluripotent stem cells respond to Wnt, Nodal and LIF signalling to produce expandable naive extra-embryonic endoderm</article-title><source>Development</source><year>2019</year><volume>146</volume><pub-id pub-id-type="pmid">31740534</pub-id></element-citation></ref><ref id="R53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipiec</surname><given-names>MA</given-names></name><name><surname>Bem</surname><given-names>J</given-names></name><name><surname>Kozinski</surname><given-names>K</given-names></name><name><surname>Chakraborty</surname><given-names>C</given-names></name><name><surname>Urban-Ciecko</surname><given-names>J</given-names></name><name><surname>Zajkowski</surname><given-names>T</given-names></name><name><surname>Dabrowski</surname><given-names>M</given-names></name><name><surname>Szewczyk</surname><given-names>LM</given-names></name><name><surname>Toval</surname><given-names>A</given-names></name><name><surname>Ferran</surname><given-names>JL</given-names></name><etal/></person-group><article-title>TCF7L2 regulates postmitotic differentiation programmes and excitability patterns in the thalamus</article-title><source>Development</source><year>2020</year><volume>147</volume><pub-id pub-id-type="pmcid">PMC7473649</pub-id><pub-id pub-id-type="pmid">32675279</pub-id><pub-id pub-id-type="doi">10.1242/dev.190181</pub-id></element-citation></ref><ref id="R54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>van den Broek</surname><given-names>O</given-names></name><name><surname>Destree</surname><given-names>O</given-names></name><name><surname>Hoppler</surname><given-names>S</given-names></name></person-group><article-title>Distinct roles for Xenopus Tcf/Lef genes in mediating specific responses to Wnt/beta-catenin signalling in mesoderm development</article-title><source>Development</source><year>2005</year><volume>132</volume><fpage>5375</fpage><lpage>5385</lpage><pub-id pub-id-type="pmid">16291789</pub-id></element-citation></ref><ref id="R55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name></person-group><article-title>Inhibition of Wnt/beta-catenin signaling by IWR1 induces expression of Foxd3 to promote mouse epiblast stem cell self-renewal</article-title><source>Biochem Biophys Res Commun</source><year>2017</year><volume>490</volume><fpage>616</fpage><lpage>622</lpage><pub-id pub-id-type="pmid">28630002</pub-id></element-citation></ref><ref id="R56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Wakamiya</surname><given-names>M</given-names></name><name><surname>Shea</surname><given-names>MJ</given-names></name><name><surname>Albrecht</surname><given-names>U</given-names></name><name><surname>Behringer</surname><given-names>RR</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name></person-group><article-title>Requirement for Wnt3 in vertebrate axis formation</article-title><source>Nature Genetics</source><year>1999</year><pub-id pub-id-type="pmid">10431240</pub-id></element-citation></ref><ref id="R57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Kodithuwakku</surname><given-names>SP</given-names></name><name><surname>Ng</surname><given-names>PY</given-names></name><name><surname>Chai</surname><given-names>J</given-names></name><name><surname>Ng</surname><given-names>EHY</given-names></name><name><surname>Yeung</surname><given-names>WSB</given-names></name><name><surname>Ho</surname><given-names>PC</given-names></name><name><surname>Lee</surname><given-names>KF</given-names></name></person-group><article-title>Excessive ovarian stimulation up-regulates the Wnt-signaling molecule DKK1 in human endometrium and may affect implantation: An in vitro co-culture study</article-title><source>Human Reproduction</source><year>2010</year><pub-id pub-id-type="pmid">19955106</pub-id></element-citation></ref><ref id="R58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname><given-names>KM</given-names></name><name><surname>Ang</surname><given-names>LT</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Ang</surname><given-names>J</given-names></name><name><surname>Auyeong</surname><given-names>JQ</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><name><surname>Choo</surname><given-names>SH</given-names></name><name><surname>Lim</surname><given-names>CYY</given-names></name><name><surname>Nichane</surname><given-names>M</given-names></name><etal/></person-group><article-title>Efficient endoderm induction from human pluripotent stem cells by logically directing signals controlling lineage bifurcations</article-title><source>Cell Stem Cell</source><year>2014</year><pub-id pub-id-type="pmcid">PMC4045507</pub-id><pub-id pub-id-type="pmid">24412311</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2013.12.007</pub-id></element-citation></ref><ref id="R59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyashenko</surname><given-names>N</given-names></name><name><surname>Winter</surname><given-names>M</given-names></name><name><surname>Migliorini</surname><given-names>D</given-names></name><name><surname>Biechele</surname><given-names>T</given-names></name><name><surname>Moon</surname><given-names>RT</given-names></name><name><surname>Hartmann</surname><given-names>C</given-names></name></person-group><article-title>Differential requirement for the dual functions of β-catenin in embryonic stem cell self-renewal and germ layer formation</article-title><source>Nature Cell Biology</source><year>2011</year><pub-id pub-id-type="pmcid">PMC3130149</pub-id><pub-id pub-id-type="pmid">21685890</pub-id><pub-id pub-id-type="doi">10.1038/ncb2260</pub-id></element-citation></ref><ref id="R60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackinlay</surname><given-names>KM</given-names></name><name><surname>Weatherbee</surname><given-names>BA</given-names></name><name><surname>Souza Rosa</surname><given-names>V</given-names></name><name><surname>Handford</surname><given-names>CE</given-names></name><name><surname>Hudson</surname><given-names>G</given-names></name><name><surname>Coorens</surname><given-names>T</given-names></name><name><surname>Pereira</surname><given-names>LV</given-names></name><name><surname>Behjati</surname><given-names>S</given-names></name><name><surname>Vallier</surname><given-names>L</given-names></name><name><surname>Shahbazi</surname><given-names>MN</given-names></name><etal/></person-group><article-title>An in vitro stem cell model of human epiblast and yolk sac interaction</article-title><source>eLife</source><year>2021</year><pub-id pub-id-type="pmcid">PMC8370770</pub-id><pub-id pub-id-type="pmid">34403333</pub-id><pub-id pub-id-type="doi">10.7554/eLife.63930</pub-id></element-citation></ref><ref id="R61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahendram</surname><given-names>S</given-names></name><name><surname>Kelly</surname><given-names>KF</given-names></name><name><surname>Paez-Parent</surname><given-names>S</given-names></name><name><surname>Mahmood</surname><given-names>S</given-names></name><name><surname>Polena</surname><given-names>E</given-names></name><name><surname>Cooney</surname><given-names>AJ</given-names></name><name><surname>Doble</surname><given-names>BW</given-names></name></person-group><article-title>Ectopic γ-catenin Expression Partially Mimics the Effects of Stabilized β-catenin on Embryonic Stem Cell Differentiation</article-title><source>PLoS ONE</source><year>2013</year><pub-id pub-id-type="pmcid">PMC3664634</pub-id><pub-id pub-id-type="pmid">23724138</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0065320</pub-id></element-citation></ref><ref id="R62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martello</surname><given-names>G</given-names></name><name><surname>Sugimoto</surname><given-names>T</given-names></name><name><surname>Diamanti</surname><given-names>E</given-names></name><name><surname>Joshi</surname><given-names>A</given-names></name><name><surname>Hannah</surname><given-names>R</given-names></name><name><surname>Ohtsuka</surname><given-names>S</given-names></name><name><surname>Gottgens</surname><given-names>B</given-names></name><name><surname>Niwa</surname><given-names>H</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name></person-group><article-title>Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal</article-title><source>Cell Stem Cell</source><year>2012</year><volume>11</volume><fpage>491</fpage><lpage>504</lpage><pub-id pub-id-type="pmcid">PMC3465555</pub-id><pub-id pub-id-type="pmid">23040478</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2012.06.008</pub-id></element-citation></ref><ref id="R63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><article-title>Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells</article-title><source>Proc Natl Acad Sci U S A</source><year>1981</year><volume>78</volume><fpage>7634</fpage><lpage>7638</lpage><pub-id pub-id-type="pmcid">PMC349323</pub-id><pub-id pub-id-type="pmid">6950406</pub-id><pub-id pub-id-type="doi">10.1073/pnas.78.12.7634</pub-id></element-citation></ref><ref id="R64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martyn</surname><given-names>I</given-names></name><name><surname>Brivanlou</surname><given-names>AH</given-names></name><name><surname>Siggia</surname><given-names>ED</given-names></name></person-group><article-title>A wave of WNT signaling balanced by secreted inhibitors controls primitive streak formation in micropattern colonies of human embryonic stem cells</article-title><source>Development (Cambridge)</source><year>2019</year><pub-id pub-id-type="pmcid">PMC6451321</pub-id><pub-id pub-id-type="pmid">30814117</pub-id><pub-id pub-id-type="doi">10.1242/dev.172791</pub-id></element-citation></ref><ref id="R65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massey</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Alvarenga</surname><given-names>O</given-names></name><name><surname>Saez</surname><given-names>T</given-names></name><name><surname>Schmerer</surname><given-names>M</given-names></name><name><surname>Warmflash</surname><given-names>A</given-names></name></person-group><article-title>Synergy with TGFbeta ligands switches WNT pathway dynamics from transient to sustained during human pluripotent cell differentiation</article-title><source>Proc Natl Acad Sci U S A</source><year>2019</year><volume>116</volume><fpage>4989</fpage><lpage>4998</lpage><pub-id pub-id-type="pmcid">PMC6421465</pub-id><pub-id pub-id-type="pmid">30819898</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1815363116</pub-id></element-citation></ref><ref id="R66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>CD</given-names></name><name><surname>Giclais</surname><given-names>SM</given-names></name><name><surname>Alsehly</surname><given-names>F</given-names></name><name><surname>Hoppler</surname><given-names>S</given-names></name></person-group><article-title>Diverse LEF/TCF Expression in Human Colorectal Cancer Correlates with Altered Wnt-Regulated Transcriptome in a Meta-Analysis of Patient Biopsies</article-title><source>Genes (Basel)</source><year>2020</year><volume>11</volume><pub-id pub-id-type="pmcid">PMC7288467</pub-id><pub-id pub-id-type="pmid">32403323</pub-id><pub-id pub-id-type="doi">10.3390/genes11050538</pub-id></element-citation></ref><ref id="R67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meek</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Oh</surname><given-names>T</given-names></name><name><surname>Watson</surname><given-names>T</given-names></name><name><surname>Olavarrieta</surname><given-names>J</given-names></name><name><surname>Sutherland</surname><given-names>L</given-names></name><name><surname>Carlson</surname><given-names>DF</given-names></name><name><surname>Salzano</surname><given-names>A</given-names></name><name><surname>Chandra</surname><given-names>T</given-names></name><name><surname>Joshi</surname><given-names>A</given-names></name><etal/></person-group><article-title>A Stem Cell Reporter for Investigating Pluripotency and Self-Renewal in the Rat</article-title><source>Stem Cell Reports</source><year>2020</year><pub-id pub-id-type="pmcid">PMC6962659</pub-id><pub-id pub-id-type="pmid">31902707</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2019.12.001</pub-id></element-citation></ref><ref id="R68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meek</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Sutherland</surname><given-names>L</given-names></name><name><surname>Nilges</surname><given-names>B</given-names></name><name><surname>Buehr</surname><given-names>M</given-names></name><name><surname>Tomlinson</surname><given-names>SR</given-names></name><name><surname>Thomson</surname><given-names>AJ</given-names></name><name><surname>Burdon</surname><given-names>T</given-names></name></person-group><article-title>Tuning of β-Catenin activity is required to stabilize self-renewal of rat embryonic stem cells</article-title><source>Stem Cells</source><year>2013</year><pub-id pub-id-type="pmid">23843312</pub-id></element-citation></ref><ref id="R69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>S</given-names></name><name><surname>Polena</surname><given-names>E</given-names></name><name><surname>Gordon</surname><given-names>V</given-names></name><name><surname>Abdulla</surname><given-names>S</given-names></name><name><surname>Mahendram</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Blais</surname><given-names>A</given-names></name><name><surname>Wood</surname><given-names>GA</given-names></name><name><surname>Dvorkin-Gheva</surname><given-names>A</given-names></name><name><surname>Doble</surname><given-names>BW</given-names></name></person-group><article-title>A Single TCF Transcription Factor, Regardless of Its Activation Capacity, Is Sufficient for Effective Trilineage Differentiation of ESCs</article-title><source>Cell Reports</source><year>2017</year><pub-id pub-id-type="pmid">28877475</pub-id></element-citation></ref><ref id="R70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Luedeke</surname><given-names>DM</given-names></name><name><surname>McCoy</surname><given-names>L</given-names></name><name><surname>Iwafuchi</surname><given-names>M</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name></person-group><article-title>SOX transcription factors direct TCF-independent WNT/beta-catenin responsive transcription to govern cell fate in human pluripotent stem cells</article-title><source>Cell Rep</source><year>2022</year><volume>40</volume><elocation-id>111247</elocation-id><pub-id pub-id-type="pmcid">PMC10123531</pub-id><pub-id pub-id-type="pmid">36001974</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.111247</pub-id></element-citation></ref><ref id="R71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulas</surname><given-names>C</given-names></name><name><surname>Kalkan</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name></person-group><article-title>NODAL Secures Pluripotency upon Embryonic Stem Cell Progression from the Ground State</article-title><source>Stem Cell Reports</source><year>2017</year><pub-id pub-id-type="pmcid">PMC5511111</pub-id><pub-id pub-id-type="pmid">28669603</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2017.05.033</pub-id></element-citation></ref><ref id="R72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name></person-group><article-title>Naive and primed pluripotent states</article-title><source>Cell Stem Cell</source><year>2009</year><volume>4</volume><fpage>487</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">19497275</pub-id></element-citation></ref><ref id="R73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusse</surname><given-names>R</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><article-title>Wnt/beta-Catenin Signaling, Disease, and Emerging Therapeutic Modalities</article-title><source>Cell</source><year>2017</year><volume>169</volume><fpage>985</fpage><lpage>999</lpage><pub-id pub-id-type="pmid">28575679</pub-id></element-citation></ref><ref id="R74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oldak</surname><given-names>B</given-names></name><name><surname>Wildschutz</surname><given-names>E</given-names></name><name><surname>Bondarenko</surname><given-names>V</given-names></name><name><surname>Comar</surname><given-names>MY</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Aguilera-Castrejon</surname><given-names>A</given-names></name><name><surname>Tarazi</surname><given-names>S</given-names></name><name><surname>Viukov</surname><given-names>S</given-names></name><name><surname>Pham</surname><given-names>TXA</given-names></name><name><surname>Ashouokhi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Complete human day 14 post-implantation embryo models from naive ES cells</article-title><source>Nature</source><year>2023</year><volume>622</volume><fpage>562</fpage><lpage>573</lpage><pub-id pub-id-type="pmcid">PMC10584686</pub-id><pub-id pub-id-type="pmid">37673118</pub-id><pub-id pub-id-type="doi">10.1038/s41586-023-06604-5</pub-id></element-citation></ref><ref id="R75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oosterwegel</surname><given-names>M</given-names></name><name><surname>van de Wetering</surname><given-names>M</given-names></name><name><surname>Timmerman</surname><given-names>J</given-names></name><name><surname>Kruisbeek</surname><given-names>A</given-names></name><name><surname>Destree</surname><given-names>O</given-names></name><name><surname>Meijlink</surname><given-names>F</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><article-title>Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis</article-title><source>Development</source><year>1993</year><volume>118</volume><fpage>439</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">8223271</pub-id></element-citation></ref><ref id="R76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osnato</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>S</given-names></name><name><surname>Krueger</surname><given-names>C</given-names></name><name><surname>Andrews</surname><given-names>S</given-names></name><name><surname>Collier</surname><given-names>AJ</given-names></name><name><surname>Nakanoh</surname><given-names>S</given-names></name><name><surname>Quiroga Londono</surname><given-names>M</given-names></name><name><surname>Wesley</surname><given-names>BT</given-names></name><name><surname>Muraro</surname><given-names>D</given-names></name><name><surname>Brumm</surname><given-names>AS</given-names></name><etal/></person-group><article-title>TGFbeta signalling is required to maintain pluripotency of human naive pluripotent stem cells</article-title><source>Elife</source><year>2021</year><volume>10</volume><pub-id pub-id-type="pmcid">PMC8410071</pub-id><pub-id pub-id-type="pmid">34463252</pub-id><pub-id pub-id-type="doi">10.7554/eLife.67259</pub-id></element-citation></ref><ref id="R77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pham</surname><given-names>TXA</given-names></name><name><surname>Panda</surname><given-names>A</given-names></name><name><surname>Kagawa</surname><given-names>H</given-names></name><name><surname>To</surname><given-names>SK</given-names></name><name><surname>Ertekin</surname><given-names>C</given-names></name><name><surname>Georgolopoulos</surname><given-names>G</given-names></name><name><surname>van Knippenberg</surname><given-names>S</given-names></name><name><surname>Allsop</surname><given-names>RN</given-names></name><name><surname>Bruneau</surname><given-names>A</given-names></name><name><surname>Chui</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Modeling human extraembryonic mesoderm cells using naive pluripotent stem cells</article-title><source>Cell Stem Cell</source><year>2022</year><volume>29</volume><fpage>1346</fpage><lpage>1365</lpage><elocation-id>e1310</elocation-id><pub-id pub-id-type="pmcid">PMC9438972</pub-id><pub-id pub-id-type="pmid">36055191</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2022.08.001</pub-id></element-citation></ref><ref id="R78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollheimer</surname><given-names>J</given-names></name><name><surname>Loregger</surname><given-names>T</given-names></name><name><surname>Sonderegger</surname><given-names>S</given-names></name><name><surname>Saleh</surname><given-names>L</given-names></name><name><surname>Bauer</surname><given-names>S</given-names></name><name><surname>Bilban</surname><given-names>M</given-names></name><name><surname>Czerwenka</surname><given-names>K</given-names></name><name><surname>Husslein</surname><given-names>P</given-names></name><name><surname>Knofler</surname><given-names>M</given-names></name></person-group><article-title>Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast</article-title><source>Am J Pathol</source><year>2006</year><volume>168</volume><fpage>1134</fpage><lpage>1147</lpage><pub-id pub-id-type="pmcid">PMC1606554</pub-id><pub-id pub-id-type="pmid">16565489</pub-id><pub-id pub-id-type="doi">10.2353/ajpath.2006.050686</pub-id></element-citation></ref><ref id="R79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramakrishnan</surname><given-names>AB</given-names></name><name><surname>Cadigan</surname><given-names>KM</given-names></name></person-group><article-title>Wnt target genes and where to find them</article-title><source>F1000Res</source><year>2017</year><volume>6</volume><fpage>746</fpage><pub-id pub-id-type="pmcid">PMC5464219</pub-id><pub-id pub-id-type="pmid">28649368</pub-id><pub-id pub-id-type="doi">10.12688/f1000research.11034.1</pub-id></element-citation></ref><ref id="R80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Perez</surname><given-names>JA</given-names></name><name><surname>Magnuson</surname><given-names>T</given-names></name></person-group><article-title>Primitive streak formation in mice is preceded by localized activation of Brachyury and Wnt3</article-title><source>Dev Biol</source><year>2005</year><volume>288</volume><fpage>363</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">16289026</pub-id></element-citation></ref><ref id="R81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>RM</given-names></name><name><surname>Loh</surname><given-names>KM</given-names></name><name><surname>Amita</surname><given-names>M</given-names></name><name><surname>Bernardo</surname><given-names>AS</given-names></name><name><surname>Adachi</surname><given-names>K</given-names></name><name><surname>Alexenko</surname><given-names>AP</given-names></name><name><surname>Schust</surname><given-names>DJ</given-names></name><name><surname>Schulz</surname><given-names>LC</given-names></name><name><surname>Telugu</surname><given-names>BP</given-names></name><name><surname>Ezashi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Differentiation of trophoblast cells from human embryonic stem cells: to be or not to be?</article-title><source>Reproduction</source><year>2014</year><volume>147</volume><fpage>D1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">24518070</pub-id></element-citation></ref><ref id="R82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roose</surname><given-names>J</given-names></name><name><surname>Huls</surname><given-names>G</given-names></name><name><surname>van Beest</surname><given-names>M</given-names></name><name><surname>Moerer</surname><given-names>P</given-names></name><name><surname>van der Horn</surname><given-names>K</given-names></name><name><surname>Goldschmeding</surname><given-names>R</given-names></name><name><surname>Logtenberg</surname><given-names>T</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><article-title>Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1</article-title><source>Science</source><year>1999</year><volume>285</volume><fpage>1923</fpage><lpage>1926</lpage><pub-id pub-id-type="pmid">10489374</pub-id></element-citation></ref><ref id="R83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>C</given-names></name><name><surname>Boroviak</surname><given-names>TE</given-names></name></person-group><article-title>Origin and function of the yolk sac in primate embryogenesis</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><elocation-id>3760</elocation-id><pub-id pub-id-type="pmcid">PMC7387521</pub-id><pub-id pub-id-type="pmid">32724077</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-17575-w</pub-id></element-citation></ref><ref id="R84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rostovskaya</surname><given-names>M</given-names></name><name><surname>Andrews</surname><given-names>S</given-names></name><name><surname>Reik</surname><given-names>W</given-names></name><name><surname>Rugg-Gunn</surname><given-names>PJ</given-names></name></person-group><article-title>Amniogenesis occurs in two independent waves in primates</article-title><source>Cell stem cell</source><year>2022</year><pub-id pub-id-type="pmcid">PMC9627701</pub-id><pub-id pub-id-type="pmid">35439430</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2022.03.014</pub-id></element-citation></ref><ref id="R85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rostovskaya</surname><given-names>M</given-names></name><name><surname>Stirparo</surname><given-names>GG</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name></person-group><article-title>Capacitation of human naive pluripotent stem cells for multi-lineage differentiation</article-title><source>Development</source><year>2019</year><volume>146</volume><pub-id pub-id-type="pmcid">PMC6467473</pub-id><pub-id pub-id-type="pmid">30944104</pub-id><pub-id pub-id-type="doi">10.1242/dev.172916</pub-id></element-citation></ref><ref id="R86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagrac</surname><given-names>D</given-names></name><name><surname>Sisli</surname><given-names>HB</given-names></name><name><surname>Dogan</surname><given-names>A</given-names></name></person-group><article-title>Apelin Receptor Signaling During Mesoderm Development</article-title><source>Adv Exp Med Biol</source><year>2020</year><volume>1298</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">32648246</pub-id></element-citation></ref><ref id="R87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra</surname><given-names>RA</given-names></name><name><surname>Hoverter</surname><given-names>NP</given-names></name><name><surname>Ramirez</surname><given-names>RN</given-names></name><name><surname>Vuong</surname><given-names>LM</given-names></name><name><surname>Mortazavi</surname><given-names>A</given-names></name><name><surname>Merrill</surname><given-names>BJ</given-names></name><name><surname>Waterman</surname><given-names>ML</given-names></name><name><surname>Donovan</surname><given-names>PJ</given-names></name></person-group><article-title>TCF7L1 suppresses primitive streak gene expression to support human embryonic stem cell pluripotency</article-title><source>Development (Cambridge, England)</source><year>2018</year><pub-id pub-id-type="pmcid">PMC5869011</pub-id><pub-id pub-id-type="pmid">29361574</pub-id><pub-id pub-id-type="doi">10.1242/dev.161075</pub-id></element-citation></ref><ref id="R88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stirparo</surname><given-names>GG</given-names></name><name><surname>Boroviak</surname><given-names>T</given-names></name><name><surname>Guo</surname><given-names>G</given-names></name><name><surname>Nichols</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Bertone</surname><given-names>P</given-names></name></person-group><article-title>Integrated analysis of single-cell embryo data yields a unified transcriptome signature for the human pre-implantation epiblast</article-title><source>Development (Cambridge)</source><year>2018</year><pub-id pub-id-type="pmcid">PMC5818005</pub-id><pub-id pub-id-type="pmid">29361568</pub-id><pub-id pub-id-type="doi">10.1242/dev.158501</pub-id></element-citation></ref><ref id="R89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugimoto</surname><given-names>M</given-names></name><name><surname>Kondo</surname><given-names>M</given-names></name><name><surname>Koga</surname><given-names>Y</given-names></name><name><surname>Shiura</surname><given-names>H</given-names></name><name><surname>Ikeda</surname><given-names>R</given-names></name><name><surname>Hirose</surname><given-names>M</given-names></name><name><surname>Ogura</surname><given-names>A</given-names></name><name><surname>Murakami</surname><given-names>A</given-names></name><name><surname>Yoshiki</surname><given-names>A</given-names></name><name><surname>De Sousa Lopes</surname><given-names>SMC</given-names></name><etal/></person-group><article-title>A simple and robust method for establishing homogeneous mouse epiblast stem cell lines by Wnt inhibition</article-title><source>Stem Cell Reports</source><year>2015</year><pub-id pub-id-type="pmcid">PMC4400648</pub-id><pub-id pub-id-type="pmid">25818811</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2015.02.014</pub-id></element-citation></ref><ref id="R90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumi</surname><given-names>T</given-names></name><name><surname>Oki</surname><given-names>S</given-names></name><name><surname>Kitajima</surname><given-names>K</given-names></name><name><surname>Meno</surname><given-names>C</given-names></name></person-group><article-title>Epiblast Ground State Is Controlled by Canonical Wnt/β-Catenin Signaling in the Postimplantation Mouse Embryo and Epiblast Stem Cells</article-title><source>PLoS ONE</source><year>2013</year><pub-id pub-id-type="pmcid">PMC3653965</pub-id><pub-id pub-id-type="pmid">23691040</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0063378</pub-id></element-citation></ref><ref id="R91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ying</surname><given-names>QL</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name></person-group><article-title>β-catenin coordinates with Jup and the TCF1/GATA6 axis to regulate human embryonic stem cell fate</article-title><source>Developmental Biology</source><year>2017</year><pub-id pub-id-type="pmid">28943339</pub-id></element-citation></ref><ref id="R92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>S</given-names></name><name><surname>Stark</surname><given-names>KL</given-names></name><name><surname>Shea</surname><given-names>MJ</given-names></name><name><surname>Vassileva</surname><given-names>G</given-names></name><name><surname>McMahon</surname><given-names>JA</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name></person-group><article-title>Wnt-3a regulates somite and tailbud formation in the mouse embryo</article-title><source>Genes Dev</source><year>1994</year><volume>8</volume><fpage>174</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">8299937</pub-id></element-citation></ref><ref id="R93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takashima</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>G</given-names></name><name><surname>Loos</surname><given-names>R</given-names></name><name><surname>Nichols</surname><given-names>J</given-names></name><name><surname>Ficz</surname><given-names>G</given-names></name><name><surname>Krueger</surname><given-names>F</given-names></name><name><surname>Oxley</surname><given-names>D</given-names></name><name><surname>Santos</surname><given-names>F</given-names></name><name><surname>Clarke</surname><given-names>J</given-names></name><name><surname>Mansfield</surname><given-names>W</given-names></name><etal/></person-group><article-title>Resetting transcription factor control circuitry toward ground-state pluripotency in human</article-title><source>Cell</source><year>2014</year><volume>158</volume><fpage>1254</fpage><lpage>1269</lpage><pub-id pub-id-type="pmcid">PMC4162745</pub-id><pub-id pub-id-type="pmid">25215486</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2014.08.029</pub-id></element-citation></ref><ref id="R94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tam</surname><given-names>PP</given-names></name><name><surname>Behringer</surname><given-names>RR</given-names></name></person-group><article-title>Mouse gastrulation: the formation of a mammalian body plan</article-title><source>Mech Dev</source><year>1997</year><volume>68</volume><fpage>3</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">9431800</pub-id></element-citation></ref><ref id="R95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesar</surname><given-names>PJ</given-names></name><name><surname>Chenoweth</surname><given-names>JG</given-names></name><name><surname>Brook</surname><given-names>FA</given-names></name><name><surname>Davies</surname><given-names>TJ</given-names></name><name><surname>Evans</surname><given-names>EP</given-names></name><name><surname>Mack</surname><given-names>DL</given-names></name><name><surname>Gardner</surname><given-names>RL</given-names></name><name><surname>McKay</surname><given-names>RD</given-names></name></person-group><article-title>New cell lines from mouse epiblast share defining features with human embryonic stem cells</article-title><source>Nature</source><year>2007</year><volume>448</volume><fpage>196</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">17597760</pub-id></element-citation></ref><ref id="R96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theunissen</surname><given-names>TW</given-names></name><name><surname>Powell</surname><given-names>BE</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Mitalipova</surname><given-names>M</given-names></name><name><surname>Faddah</surname><given-names>DA</given-names></name><name><surname>Reddy</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>ZP</given-names></name><name><surname>Maetzel</surname><given-names>D</given-names></name><name><surname>Ganz</surname><given-names>K</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><etal/></person-group><article-title>Systematic identification of culture conditions for induction and maintenance of naive human pluripotency</article-title><source>Cell Stem Cell</source><year>2014</year><pub-id pub-id-type="pmcid">PMC4534765</pub-id><pub-id pub-id-type="pmid">28903030</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2014.09.003</pub-id></element-citation></ref><ref id="R97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>JA</given-names></name><name><surname>Itskovitz-Eldor</surname><given-names>J</given-names></name><name><surname>Shapiro</surname><given-names>SS</given-names></name><name><surname>Waknitz</surname><given-names>MA</given-names></name><name><surname>Swiergiel</surname><given-names>JJ</given-names></name><name><surname>Marshall</surname><given-names>VS</given-names></name><name><surname>Jones</surname><given-names>JM</given-names></name></person-group><article-title>Embryonic stem cell lines derived from human blastocysts</article-title><source>Science</source><year>1998</year><volume>282</volume><fpage>1145</fpage><lpage>1147</lpage><pub-id pub-id-type="pmid">9804556</pub-id></element-citation></ref><ref id="R98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres-Aguila</surname><given-names>NP</given-names></name><name><surname>Salonna</surname><given-names>M</given-names></name><name><surname>Hoppler</surname><given-names>S</given-names></name><name><surname>Ferrier</surname><given-names>DEK</given-names></name></person-group><article-title>Evolutionary diversification of the canonical Wnt signaling effector TCF/LEF in chordates</article-title><source>Dev Growth Differ</source><year>2022</year><volume>64</volume><fpage>120</fpage><lpage>137</lpage><pub-id pub-id-type="pmcid">PMC9303524</pub-id><pub-id pub-id-type="pmid">35048372</pub-id><pub-id pub-id-type="doi">10.1111/dgd.12771</pub-id></element-citation></ref><ref id="R99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsakiridis</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Blin</surname><given-names>G</given-names></name><name><surname>Skylaki</surname><given-names>S</given-names></name><name><surname>Wymeersch</surname><given-names>F</given-names></name><name><surname>Osorno</surname><given-names>R</given-names></name><name><surname>Economou</surname><given-names>C</given-names></name><name><surname>Karagianni</surname><given-names>E</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Lowell</surname><given-names>S</given-names></name><etal/></person-group><article-title>Distinct Wnt-driven primitive streak-like populations reflect in vivo lineage precursors</article-title><source>Development</source><year>2014</year><volume>141</volume><fpage>1209</fpage><lpage>1221</lpage><pub-id pub-id-type="pmcid">PMC3943179</pub-id><pub-id pub-id-type="pmid">24595287</pub-id><pub-id pub-id-type="doi">10.1242/dev.101014</pub-id></element-citation></ref><ref id="R100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turbendian</surname><given-names>HK</given-names></name><name><surname>Gordillo</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>TC</given-names></name><name><surname>Tang</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Fishman</surname><given-names>GI</given-names></name><name><surname>Evans</surname><given-names>T</given-names></name></person-group><article-title>GATA factors efficiently direct cardiac fate from embryonic stem cells</article-title><source>Development</source><year>2013</year><volume>140</volume><fpage>1639</fpage><lpage>1644</lpage><pub-id pub-id-type="pmcid">PMC3621482</pub-id><pub-id pub-id-type="pmid">23487308</pub-id><pub-id pub-id-type="doi">10.1242/dev.093260</pub-id></element-citation></ref><ref id="R101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyser</surname><given-names>RCV</given-names></name><name><surname>Mahammadov</surname><given-names>E</given-names></name><name><surname>Nakanoh</surname><given-names>S</given-names></name><name><surname>Vallier</surname><given-names>L</given-names></name><name><surname>Scialdone</surname><given-names>A</given-names></name><name><surname>Srinivas</surname><given-names>S</given-names></name></person-group><article-title>Single-cell transcriptomic characterization of a gastrulating human embryo</article-title><source>Nature</source><year>2021</year><volume>600</volume><fpage>285</fpage><lpage>289</lpage><pub-id pub-id-type="pmcid">PMC7615353</pub-id><pub-id pub-id-type="pmid">34789876</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-04158-y</pub-id></element-citation></ref><ref id="R102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallier</surname><given-names>L</given-names></name><name><surname>Alexander</surname><given-names>M</given-names></name><name><surname>Pedersen</surname><given-names>RA</given-names></name></person-group><article-title>Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells</article-title><source>Journal of Cell Science</source><year>2005</year><pub-id pub-id-type="pmid">16179608</pub-id></element-citation></ref><ref id="R103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>M</given-names></name><name><surname>Loh</surname><given-names>NY</given-names></name><name><surname>Sabaratnam</surname><given-names>R</given-names></name><name><surname>Vasan</surname><given-names>SK</given-names></name><name><surname>van Dam</surname><given-names>AD</given-names></name><name><surname>Todorcevic</surname><given-names>M</given-names></name><name><surname>Neville</surname><given-names>MJ</given-names></name><name><surname>Toledo</surname><given-names>E</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Christodoulides</surname><given-names>C</given-names></name></person-group><article-title>TCF7L2 plays a complex role in human adipose progenitor biology, which might contribute to genetic susceptibility to type 2 diabetes</article-title><source>Metabolism</source><year>2022</year><volume>133</volume><elocation-id>155240</elocation-id><pub-id pub-id-type="pmid">35697299</pub-id></element-citation></ref><ref id="R104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallmen</surname><given-names>B</given-names></name><name><surname>Schrempp</surname><given-names>M</given-names></name><name><surname>Hecht</surname><given-names>A</given-names></name></person-group><article-title>Intrinsic properties of Tcf1 and Tcf4 splice variants determine cell-type-specific Wnt/β-catenin target gene expression</article-title><source>Nucleic Acids Research</source><year>2012</year><pub-id pub-id-type="pmcid">PMC3479169</pub-id><pub-id pub-id-type="pmid">22859735</pub-id><pub-id pub-id-type="doi">10.1093/nar/gks690</pub-id></element-citation></ref><ref id="R105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname><given-names>J</given-names></name><name><surname>Rose</surname><given-names>K</given-names></name><name><surname>Haghighi</surname><given-names>EB</given-names></name><name><surname>Lamprecht</surname><given-names>C</given-names></name><name><surname>Rauen</surname><given-names>G</given-names></name><name><surname>Freihen</surname><given-names>V</given-names></name><name><surname>Kesselring</surname><given-names>R</given-names></name><name><surname>Boerries</surname><given-names>M</given-names></name><name><surname>Hecht</surname><given-names>A</given-names></name></person-group><article-title>Loss of the nuclear Wnt pathway effector TCF7L2 promotes migration and invasion of human colorectal cancer cells</article-title><source>Oncogene</source><year>2020</year><volume>39</volume><fpage>3893</fpage><lpage>3909</lpage><pub-id pub-id-type="pmcid">PMC7203011</pub-id><pub-id pub-id-type="pmid">32203164</pub-id><pub-id pub-id-type="doi">10.1038/s41388-020-1259-7</pub-id></element-citation></ref><ref id="R106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wray</surname><given-names>J</given-names></name><name><surname>Kalkan</surname><given-names>T</given-names></name><name><surname>Gomez-Lopez</surname><given-names>S</given-names></name><name><surname>Eckardt</surname><given-names>D</given-names></name><name><surname>Cook</surname><given-names>A</given-names></name><name><surname>Kemler</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name></person-group><article-title>Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation</article-title><source>Nature Cell Biology</source><year>2011</year><pub-id pub-id-type="pmcid">PMC3160487</pub-id><pub-id pub-id-type="pmid">21685889</pub-id><pub-id pub-id-type="doi">10.1038/ncb2267</pub-id></element-citation></ref><ref id="R107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Ai</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>GSK3 inhibitors CHIR99021 and 6-bromoindirubin-3’-oxime inhibit microRNA maturation in mouse embryonic stem cells</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><elocation-id>8666</elocation-id><pub-id pub-id-type="pmcid">PMC4345320</pub-id><pub-id pub-id-type="pmid">25727520</pub-id><pub-id pub-id-type="doi">10.1038/srep08666</pub-id></element-citation></ref><ref id="R108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>L</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Ai</surname><given-names>Z</given-names></name><name><surname>Niu</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>K</given-names></name><etal/></person-group><article-title>A developmental landscape of 3D-cultured human pre-gastrulation embryos</article-title><source>Nature</source><year>2020</year><pub-id pub-id-type="pmid">31830756</pub-id></element-citation></ref><ref id="R109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>RH</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>DS</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Addicks</surname><given-names>GC</given-names></name><name><surname>Glennon</surname><given-names>C</given-names></name><name><surname>Zwaka</surname><given-names>TP</given-names></name><name><surname>Thomson</surname><given-names>JA</given-names></name></person-group><article-title>BMP4 initiates human embryonic stem cell differentiation to trophoblast</article-title><source>Nature Biotechnology</source><year>2002</year><pub-id pub-id-type="pmid">12426580</pub-id></element-citation></ref><ref id="R110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yabe</surname><given-names>S</given-names></name><name><surname>Alexenko</surname><given-names>AP</given-names></name><name><surname>Amita</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Schust</surname><given-names>DJ</given-names></name><name><surname>Sadovsky</surname><given-names>Y</given-names></name><name><surname>Ezashi</surname><given-names>T</given-names></name><name><surname>Roberts</surname><given-names>RM</given-names></name></person-group><article-title>Comparison of syncytiotrophoblast generated from human embryonic stem cells and from term placentas</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2016</year><pub-id pub-id-type="pmcid">PMC4868474</pub-id><pub-id pub-id-type="pmid">27051068</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1601630113</pub-id></element-citation></ref><ref id="R111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Tong</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>K</given-names></name><name><surname>Ban</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Ying</surname><given-names>QL</given-names></name></person-group><article-title>Depletion of Tcf3 and Lef1 maintains mouse embryonic stem cell self-renewal</article-title><source>Biology Open</source><year>2017</year><pub-id pub-id-type="pmcid">PMC5399551</pub-id><pub-id pub-id-type="pmid">28288968</pub-id><pub-id pub-id-type="doi">10.1242/bio.022426</pub-id></element-citation></ref><ref id="R112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>F</given-names></name><name><surname>Pereira</surname><given-names>L</given-names></name><name><surname>Hoffman</surname><given-names>JA</given-names></name><name><surname>Shy</surname><given-names>BR</given-names></name><name><surname>Yuen</surname><given-names>CM</given-names></name><name><surname>Liu</surname><given-names>DR</given-names></name><name><surname>Merrill</surname><given-names>BJ</given-names></name></person-group><article-title>Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal</article-title><source>Nat Cell Biol</source><year>2011</year><volume>13</volume><fpage>762</fpage><lpage>770</lpage><pub-id pub-id-type="pmcid">PMC3129424</pub-id><pub-id pub-id-type="pmid">21685894</pub-id><pub-id pub-id-type="doi">10.1038/ncb2283</pub-id></element-citation></ref><ref id="R113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>QL</given-names></name><name><surname>Wray</surname><given-names>J</given-names></name><name><surname>Nichols</surname><given-names>J</given-names></name><name><surname>Batlle-Morera</surname><given-names>L</given-names></name><name><surname>Doble</surname><given-names>B</given-names></name><name><surname>Woodgett</surname><given-names>J</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name></person-group><article-title>The ground state of embryonic stem cell self-renewal</article-title><source>Nature</source><year>2008</year><volume>453</volume><fpage>519</fpage><lpage>523</lpage><pub-id pub-id-type="pmcid">PMC5328678</pub-id><pub-id pub-id-type="pmid">18497825</pub-id><pub-id pub-id-type="doi">10.1038/nature06968</pub-id></element-citation></ref><ref id="R114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoney</surname><given-names>A</given-names></name><name><surname>Bai</surname><given-names>L</given-names></name><name><surname>Brivanlou</surname><given-names>AH</given-names></name><name><surname>Siggia</surname><given-names>ED</given-names></name></person-group><article-title>Mechanisms underlying WNT-mediated priming of human embryonic stem cells</article-title><source>Development</source><year>2022</year><volume>149</volume><pub-id pub-id-type="pmcid">PMC9357376</pub-id><pub-id pub-id-type="pmid">35815787</pub-id><pub-id pub-id-type="doi">10.1242/dev.200335</pub-id></element-citation></ref><ref id="R115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>RM</given-names></name><name><surname>Ewan</surname><given-names>KB</given-names></name><name><surname>Ferrer</surname><given-names>VP</given-names></name><name><surname>Allende</surname><given-names>ML</given-names></name><name><surname>Godovac-Zimmermann</surname><given-names>J</given-names></name><name><surname>Dale</surname><given-names>TC</given-names></name><name><surname>Wilson</surname><given-names>SW</given-names></name></person-group><article-title>Developmentally regulated Tcf7l2 splice variants mediate transcriptional repressor functions during eye formation</article-title><source>Elife</source><year>2019</year><volume>8</volume><pub-id pub-id-type="pmcid">PMC6908431</pub-id><pub-id pub-id-type="pmid">31829936</pub-id><pub-id pub-id-type="doi">10.7554/eLife.51447</pub-id></element-citation></ref><ref id="R116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmerlin</surname><given-names>L</given-names></name><name><surname>Park</surname><given-names>TS</given-names></name><name><surname>Huo</surname><given-names>JS</given-names></name><name><surname>Verma</surname><given-names>K</given-names></name><name><surname>Pather</surname><given-names>SR</given-names></name><name><surname>Talbot</surname><given-names>CC</given-names></name><name><surname>Agarwal</surname><given-names>J</given-names></name><name><surname>Steppan</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>YW</given-names></name><name><surname>Considine</surname><given-names>M</given-names></name><etal/></person-group><article-title>Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality</article-title><source>Development (Cambridge)</source><year>2016</year><pub-id pub-id-type="pmcid">PMC5201042</pub-id><pub-id pub-id-type="pmid">27660325</pub-id><pub-id pub-id-type="doi">10.1242/dev.138982</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><title>Difference in TCF/LEF expression between human and mouse in both naïve and primed embryonic stem cells.</title><p><bold>(A)</bold> Immunostaining of JNST mouse embryonic stem cells cultured in either 2i+LIF (naïve, top) and AFX (primed, bottom) for 48 hours for OCT4 (green), KLF4 (magenta) and TFCP2L1 (grey) with DAPI (blue). Scale bars = 100 μm.</p><p><bold>(B)</bold> Immunostaining of HNES1 embryonic stem cells for OCT4 (green), KLF17 (grey) and NANOG (magenta) after 72 hours of culture in PXGL (naïve) or AFX/StemFlex medium (primed). Scale bars = 100 μm.</p><p><bold>(C)</bold> Immunostaining of JNST mouse ES cells (2i+LIF) and HNES1 (PXGL) cells after 72 hours of culture for TCF7, TCF7L1, TCF7L2 and LEF1. Scale bars = 100 μm.</p><p><bold>(D)</bold> Flow cytometry of mouse naïve and primed cells for each TCF/LEF factor.</p><p><bold>(E)</bold> Quantification of positive cell populations from flow cytometry data. Error bars represent ±s.d. Paired T-test; ns – not significant, * &lt;0.05, ** &lt; 0.01 and *** &lt;0.001.</p><p><bold>(F)</bold> Immunostaining of pHNES1 cells cultured in StemFlex for each of the TCF/LEF factors. Scale bars = 100 μm.</p><p><bold>(G)</bold> Flow cytometry of human naïve and primed cells for each TCF/LEF factor.</p><p><bold>(H)</bold> Quantification of gated cell populations for each TCF/LEF factor in human naïve and primed cells using flow cytometry. Error bars represent ±s.d. Paired T-test; Paired T-test; ns – not significant, * &lt;0.05 and **** &lt;0.0001.</p></caption><graphic xlink:href="EMS199386-f001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><title>TCF/LEF expression in hypoblast cells.</title><p><bold>(A)</bold> Schematic of differentiation protocol to hypoblast-like cells from human naïve ES cells over 72 hours. Brightfield images of HNES3 cells 24 hours after plating (0hrs) and hypoblast-like cells in differentiation conditions 72 hours later. Undifferentiated pluripotent colony (black arrows) surrounded by nascent hypoblast-like cells (white arrows).</p><p><bold>(B)</bold> Immunostaining of undifferentiated HNES3 cells in PXGL and hypoblast cells after 72 hours for PDGFRA (magenta) and SOX17 (grey). Scale bar = 100 μm.</p><p><bold>(C)</bold> qRT-qPCR analysis of pluripotency and hypoblast markers after 96 hours either in PXGL (control) or differentiation conditions. Error bars represent ±s.d from N=3 biological replicates. Statistical analysis was performed using a paired t-test. P-values - **** = &lt;0.001.</p><p><bold>(D)</bold> qRT-PCR analysis of the <italic>TCF/LEF</italic> genes after 96 hours either in PXGL (control) or differentiation conditions. Error bars represent ±s.d from N=3 biological replicates. Statistical analysis was performed using a paired t-test. P-values - **** = &lt;0.001. ns – not significant.</p><p><bold>(E)</bold> Immunostaining of HNES3-derived hypoblast-like cells for each TCF/LEF factor (green), PDGFRA (magenta) and SOX17 (grey). Note increased TCF7L2 localisation (white arrowheads). Representative images from N=3 independent experiments. Scale bars = 100 μm.</p><p><bold>(F)</bold> Flow cytometric analysis of HNES3-derived hypoblast-like cells after 96 hours in differentiation conditions for each of the TCF/LEF factors. Representative of at least N=3 independent experiments.</p></caption><graphic xlink:href="EMS199386-f002"/></fig><fig id="F3" position="float"><label>Fig. 3</label><caption><title>Trophoblast cells express high levels of TCF7L2.</title><p><bold>(A)</bold> Schematic of differentiation protocol to trophoblast-like cells from HNES cells using PD03 and A8031 for 72 hours. Brightfield images of HNES3 cells at 24 hours after plating and 72 hours later in differentiation conditions. Scale bars = 100 μm.</p><p><bold>(B)</bold> Immunostaining of undifferentiated HNES3 cells in PXGL and differentiated trophectoderm cells after 72 hours in PDA83 for NANOG (grey) and GATA3 (magenta). Scale bars = 100 μm. Representative of 3 fields of view and N=3 independent experiments.</p><p><bold>(C)</bold> qRT-PCR analysis of pluripotent and trophectoderm marker genes after 72 hours in differentiation media. Error bars represent ±s.d. Statistical analysis was performed using a paired t-test. P-values - *** = &lt;0.01 and **** = &lt;0.001.</p><p><bold>(D)</bold> qRT-PCR analysis of TCF/LEF genes after 72 hours in differentiation media. Error bars represent ±s.d. Statistical analysis was performed using a paired t-test. P-values - **** = &lt;0.001 and ns = not significantly different.</p><p><bold>(E)</bold> Immunostaining of HNES3 cells cultured in PXGL and hypoblast cells after 72 hours in differentiation media for NANOG (grey), TCF/LEF factors as indicated (green) and GATA3 (magenta). White arrows represent TCF7L1 nuclei that also express GATA3. Note overlap of cells co-expressing TCF7L2 and either GATA3 or NANOG. Scale bars represent 100 μm.</p><p><bold>(F)</bold> Flow cytometric analysis of HNES3 and trophectoderm cells at 96 hours. Note sizeable population of cells co-expressing TCF7L2 and the trophectoderm marker (GATA3).</p></caption><graphic xlink:href="EMS199386-f003"/></fig><fig id="F4" position="float"><label>Fig. 4</label><caption><title>TCF7 and LEF1 are upregulated in response to WNT activation in human primed pluripotent ES cells.</title><p><bold>(A)</bold> Schematic of experiment of treating primed human pluripotent embryonic (ES/iPS) cells (cultured in StemFlex then switched to N2B27) with 3 μM CHIR (WNT activator) for 24 hours. Scale bars = 100 μm.</p><p><bold>(B)</bold> Immunostaining for β-Catenin (BCAT) (magenta) and OCT4 (green) in pHNES3 cells cultured in StemFlex medium for 72 hours following passaging with and without 2 μM IWP2 (WNT inhibitor) or switched to N2B27 + 3 μM CHIR for 24 hours. Scale bars = 100 μm. Insert images b<sub>1</sub> and b<sub>2</sub> are representational of each condition, respectively and scale bars = 200 um.</p><p><bold>(C)</bold> qRT-PCR analysis of <italic>AXIN2</italic> expression in control primed ES cells vs cells treated with 3 μM CHIR for 24 hours. Relative mRNA levels were normalised to <italic>UBC and ACTB</italic>. Student’s paired t-test (**** = <italic>p</italic>&lt;0.0001). Error bars indicate ±s.d.</p><p><bold>(D)</bold> Immunostaining of pHNES1 cells for BRACHYURY in control and differentiation conditions (N2B27 + 3 μM CHIR for 24 hours). Scale bars = 100 μm.</p><p><bold>(E)</bold> qRT-PCR analysis of control vs treated primed cells for <italic>NANOG, OCT4, TBXT, MIXL1</italic> and <italic>EOMES</italic>. Relative mRNA levels were normalised to <italic>UBC</italic> and <italic>ACTB</italic>. Student’s paired t-test (ns = not significant, ** = <italic>p</italic>&lt;0.01, **** = <italic>p</italic>&lt;0.0001. Error bars indicate ±s.d.</p><p><bold>(F)</bold> qRT-PCR analysis of control vs treated primed cells for <italic>TCF7, LEF1, TCF7L1</italic>, and <italic>TCF7L2</italic>. Relative mRNA levels were normalised to <italic>UBC</italic> and <italic>ACTB</italic>. Student’s paired t-test (**** = <italic>p</italic>&lt;0.0001). Error bars indicate ±s.d, N=3.</p><p><bold>(G)</bold> Immunostaining of pHNES3 cells treated with N2B27 + 3 μM CHIR for 24 hours for each TCF/LEF (green) and BRACHYURY (magenta). Representative images for N=5 independent experiments. Scale bars = 100 μm.</p><p><bold>(H)</bold> Flow cytometric analysis of control and treated (N2B27 + 3 μM CHIR for 24 hours) primed cells for each TCF/LEF factor.</p><p><bold>(I)</bold> Quantification of TCF/LEF expressing cells in hPSC control and differentiation conditions after 24 hours. Error bars indicate ±s.d. Student’s paired t-test (* = <italic>p</italic>&lt; 0.05, *** = <italic>p</italic>&lt;0.001 **** = <italic>p</italic>&lt;0.0001 and ns = not significant).</p></caption><graphic xlink:href="EMS199386-f004"/></fig><fig id="F5" position="float"><label>Fig. 5</label><caption><title>TCF7L1 and TCF7L2 remain high in Amnion differentiation.</title><p><bold>(A)</bold> Experimental protocol for amnion differentiation. Brightfield images of pHNES3 hPSCs and amnion cells. Scale bars = 100 μm.</p><p><bold>(B)</bold> Immunostaining of control pHNES3 and amnion cells after 72 hours in PDA83 + BMP4 for 72 hours of GATA3 (magenta) and NANOG (grey). Scale bars = 100 μm.</p><p><bold>(C)</bold> RT-qPCR of pluripotency and amnion markers from control and differentiated primed cell lines. Error bars represent ±s.d. Student’s paired t-test (**** = <italic>p</italic>&lt;0.0001).</p><p><bold>(D)</bold> RT-qPCR of TCF/LEF factors in undifferentiated and amnion cells after 72 hours in differentiation conditions. Error bars represent ±s.d. Student’s paired t-test (*** = <italic>p</italic>&lt;0.001 and **** = <italic>p</italic>&lt;0.0001).</p><p><bold>(E)</bold> Immunostaining of control pHNES3 and differentiated amnion cells for TCF/LEF factors (green) and GATA3 (magenta). Scale bars = 100 μm.</p><p><bold>(F)</bold> Flow cytometry of pHNES3 and amnion cells for each of the TCF/LEF factors after 72 hours.</p><p><bold>(G)</bold> Gated TCF/LEF-positive cells of pHNES3 hPSCs and amnion cells quantified using flow cytometry.</p></caption><graphic xlink:href="EMS199386-f005"/></fig><fig id="F6" position="float"><label>Fig. 6</label><caption><title>TCF/LEF factor expression in definitive endoderm from hPSCs</title><p><bold>(A)</bold> Experimental schematic to differentiate human primed ES cells towards definitive endoderm. Brightfield images show control H9 and H9-derived endoderm cells. Scale bars = 100 μm.</p><p><bold>(B)</bold> Immunostaining of control H9 cells and H9-derived definitive endoderm after 72 hours of differentiation for SOX17 (magenta) and NANOG (grey). Scale bars = 100 μm.</p><p><bold>(C)</bold> RT-qPCR analysis of control vs definitive endoderm at 72 hours. Relative mRNA levels were normalised to <italic>UBC</italic> and <italic>ACTB</italic>. Student’s paired t-test (** = p&lt; 0.01, **** = <italic>p</italic>&lt;0.0001). Error bars indicate ±s.d.</p><p><bold>(D)</bold> RT-qPCR analysis of control vs definitive endoderm at 72 hours for <italic>TCF7, TCF7L1, TCF7L2</italic> and <italic>LEF1</italic>. Relative mRNA levels were normalised to <italic>UBC</italic> and <italic>ACTB</italic>. Student’s paired t-test (ns – not significant, **** = <italic>p</italic>&lt;0.0001). Error bars indicate ±s.d, N=3.</p><p><bold>(E)</bold> Immunostaining of H9 hPSCs and definitive endoderm after 72 hours of differentiation for SOX17 (magenta) and each TCF/LEF factor (green). Scale bars = 100 μm.</p><p><bold>(F)</bold> Flow cytometric analysis of control H9 and H9-derived definitive endoderm cells for all four TCF/LEF factors after 72 hours of differentiation.</p><p><bold>(G)</bold> Quantification of TCF/LEF-positive cells in hPSCs and definitive endoderm samples after 72 hours. Error bars represent ±s.d. Student’s paired t-test (** =<italic>p</italic>&lt; 0.01, **** = <italic>p</italic>&lt;0.0001).</p></caption><graphic xlink:href="EMS199386-f006"/></fig><fig id="F7" position="float"><label>Fig. 7</label><caption><title>Schematic illustration of TCF/LEF factor expression in human pluripotent and differentiated cells</title><p>Summary diagram highlighting TCF/LEF transcription factor expression determined in this study using human pluripotent stem cells and lineage-specific differentiation. These experiments were conducted in cells that recapitulate cell lineages from a naïve and primed state of pluripotency. Green words = activation of signalling pathway and red words = inhibition of signalling pathway.</p></caption><graphic xlink:href="EMS199386-f007"/></fig></floats-group></article>